Advertisement

Lithium

  • B. Müller-Oerlinghausen
  • W P. Kaschka
Chapter
  • 79 Downloads

Zusammenfassung

Die medizinische Anwendung von Lithium-salzen wird durch die geringe therapeutische Breite des Lithiumions erschwert. Ähnlich wie bei der Therapie mit z. B. Herzglykosiden oder Theophyllin, wo die optimale Dosierung ebenfalls anhand des Serumspiegels überprüft wird, sind deshalb einige Kenntnisse der Pharmakokinetik notwendig, um einen Lithiumserumspiegel richtig zu interpretieren und um in der jeweiligen therapeutischen Situation (z. B. erste Einstellung auf Lithium, Kontrolle der laufenden Therapie, Überprüfung der Patientencompliance, Diagnose einer Intoxikation oder Dosiskorrektur nach Beginn einer relevanten Zusatzmedikation) die richtigen Kontrollmaßnahmen im richtigen Zeitintervall auszuwählen

Literatur

Literatur

  1. Alda M (1988) Method for prediction of serum lithium levels. Biol Psychiatry 24: 218–224PubMedCrossRefGoogle Scholar
  2. Amdisen A (1975) Sustained release preparations of lithium. In: Johnson Fn (cd) Lithium research and therapy. Academic Press, London, pp 197–210Google Scholar
  3. Amdisen A, Nielsfnkuusx F (1986) Relationship between standarized 12h serum lithium, mean serum lithium of the 24-hour day, dose regimen and therapeutic intervall: an evaluation based on pharmacokinetic simulations. Pharmacopsychiatry 19: 416–419PubMedCrossRefGoogle Scholar
  4. Amdisen A, Carson Sw (1986) Lithium. In: Evans We, Schentag Jj, Jusko Wj, Harrison H (eds) Applied pharmacokinetics: principles of therapeutic drug monitoring. Appl Ther: 978–1008Google Scholar
  5. Benaryeh H, Naon H, Homovrtz G, Szargej R, Giitman D (1984) Salivary and lacrimal secre-tions in patients on lithium therapy. J Psychiatr Res 18: 299–306CrossRefGoogle Scholar
  6. Caldwell 11, Wilfred C, Westlake J, Schriver RC, Bumisusr FE (1981) Steady-state lithium blood level fluctuation in man following administration of a lithium carbonate conventional and controlled-release dosage form. J Clin Phar-macol 21: 106–109Google Scholar
  7. Ehrlich B, Dianiond JM (1983) Lithium absorption: implications for sustained release lithium preparations. Lancet is 306Google Scholar
  8. Elizr1r A, Treats I (1985) Interdependency of lithium ration plasma lithium level and clinical state in patients with affective disorders. Prog Neuropsychopharmacol Biol Psychiatry 9: 167–172CrossRefGoogle Scholar
  9. Goomnrck PJ, Fieve Rr, Meltzer Hl, Inner Dl (1981) Lithium elimination halflife and duration of therapy. Clin Pharmacol Ther 29: 47–50CrossRefGoogle Scholar
  10. Greil W (1981) Pharmakologie and Kinetik des Lithiums. Bibliotheca Psychiat 161: 69–103Google Scholar
  11. Greil W, Stoitzenbi Jag MC, Mairhofer Ml, (1985) Lithium dosage in the elderly a study with matched age groups. J Affect Disord 9: 1–4PubMedCrossRefGoogle Scholar
  12. Heim W, Oelschiager H, Kreuter J, A/Hilleroerlingi Iausen B (1994) Liberation of lithium from sustained release preparations. A comparison of seven registered brands. Pharmacopsychiatry 27: 27–31PubMedCrossRefGoogle Scholar
  13. Hunter R (1988) Steadystate pharmacokinetics of lithium carbonate in healthy subjects. Br J Clin Pharmacol 25: 375–380PubMedGoogle Scholar
  14. Kampr D (1986) Lithium und Nierenfunktion. In:Mllp Roeri.Inghausen B, Greil W (Hrsg) Die Lithiumtherapie. Nutzen, Risiken, Alternativen. Springer, Berlin Heidelberg New York Tokyo, S 286–296Google Scholar
  15. Kilns CD (1998) The ups and downs of oral lithium dosing. J Clin Psychiatry 59 [Suppl] 61: 21–26Google Scholar
  16. Kukopulos A, Minnai G, Miller0facinghaiisen B (1985) The influence of mania and depression on the pharmacokinetics of lithium. A longitudinal singlecase study. J Affect Disord 8: 159–166Google Scholar
  17. Kukopuizs A, Reginald D, Johnson Fn (1992) Fluctuation in serum lithium levels as a function of mood state. Lithium 3: 195–201Google Scholar
  18. Laurilsen BJ,Mellerup E,Plfnge P,Rasmussen R,Vfstergard P,Salon M(1981)Serum lithium concentrations around the clock with different treatment regimes and the diurnal variation of the renal lithium clearance.Acta Psychiatr Stand 64: 314–319Google Scholar
  19. Lehmann K (1997) pharmakokinetik. In: Müleroerlinghausen B, Greil W, Berghöfer A (Hrsg) Die Lithiumtherapie. Nutzen, Risiken, Alternativen, 2. Aufl. Springer, Berlin Heidelberg New York Tokyo, S 148–160Google Scholar
  20. Lei Imann K, Mertin K (1974) Die Elimination von Lithium in Abhängigkeit vom Lebensalter bei Gesunden und Niereninsuffizienten. IntJ Clin Pharmacol 10: 292–298Google Scholar
  21. Leiimann K, Scherber A, Graupner K (1976) Konzentrationsverlauf von Lithium im Liquor und Augenkammercvasser nach einmaliger oraler Applikation am Menschen. Intl Clin Pharmacol 13: 22–26Google Scholar
  22. Lei Mann W, Kanarkowski R, Matkowski K, Rybakowski J (1988) Studies of lithium pharmacokinetics in patients with affective illness. Pol J Pharmacol Pharm 40: 47Google Scholar
  23. Lesar TS, Tollerson G, Kocrl M (1985) Relationship between patient variables and lithium dosage requirements. J Clin Psychiatry 46: 133–136Google Scholar
  24. Lvsxowski J, Nashirallah Ha (1981) Slowed release lithium_ a review and a comparative study. J Clin Psychopharmacol 1: 406–408CrossRefGoogle Scholar
  25. Manshaui M, L.Ippmann S, Regan W, Baldwin II (1982) Saliva lithium instability. Biot Psychiatry 17: 1449Google Scholar
  26. Mlilllroerlinghalisen B (1981) Probleme der Langzeitprophylaxe. Bibliotheca Psychiat 161: 224–236Google Scholar
  27. Mülleroerlinghausen B (1999) Drug interac-tions with lithium. A guide for clinicians. CNS Drugs 11: 41–48CrossRefGoogle Scholar
  28. Nelson MV (1988) Comparison of three lithium dosing methods in 950 „subjects“ by computer simulation. Ther Drug Monit 10: 269–274PubMedCrossRefGoogle Scholar
  29. Norman TR, Walker RG, Burrows GD (1984) Renal function-related changes in lithium kinetics. Clin Pharmacokinet 9: 349PubMedCrossRefGoogle Scholar
  30. Perry PJ, Alexander B, Prince RA, Dunner FJ (1984) Prospective evaluation of two lithium maintenance close schedules. J Clin Psychopharmacol 4: 242–246Google Scholar
  31. Philips JD,Myers DH,King RJ, Armond AR, Derha MC, Puranik A, Corbett JA, Birch NJ (1990) Pharmacokinetics of lithium in patients treated with controlled release lithium formulations. Int Clin Psychopharmacol 5: 65–69CrossRefGoogle Scholar
  32. Ritschei. WA, Barnarer M (1982) Lithium dosageregimen design by the repeated one-point method. Arzneimittelforschung 2: 98–102Google Scholar
  33. Schou M, Amidsen A, Thomsen K, Vestergaari) P, I Ietmar O, Mellerup ET, Plenge P, Rafaelsen OJ (1982) Lithium treatment regimen and renal water handling: the significance of dosage pattern and tablet type examined through comparison of results from to clinics with different treatment regimens. Psychopharmacology 77: 387PubMedCrossRefGoogle Scholar
  34. Terao T, Okuno K, Okuno T, Nakano H, Shinkai T, Ohmori O,Yoshimura R, Suzuki,Abe K (1999) A simpler and more accurate equation to predict daily lithium dose.J Clin Psychopharmacol 19: 336–340Google Scholar
  35. Thomsen K (1978) Renal handling of lithium at nontoxic and toxic serum lithium levels. A review. Dan Med Bull 215: 106–115Google Scholar
  36. Thomsen K, Scxou M (1999) Avoidance of lithium intoxication: advice based on knowledge about the renal lithium clearance under various circumstances. Pharmacopsychiatry 32: 83–86PubMedCrossRefGoogle Scholar
  37. Thornhill DP (1981) The biological disposition and kinetics of lithium. Biopharmceut DrugDispos 2: 305CrossRefGoogle Scholar
  38. Thornhill DP, Field SP (1982) Distribution of lithium elimination rates in a selected population of psychiatric patients. Eur J Clin Pharmacol 21: 351–354PubMedCrossRefGoogle Scholar
  39. Tel Th MJ, Mcrphy TK, Evans DL (1998) Special considerations: use of lithium in children, adolescents, and elderly populations. J Clin Psychiatry 59 [Suppl 6]: 66–73Google Scholar
  40. Tyrer SP(1978)The choice of lithium preparation and how to give it.In:Jotinson Fn, (eds)Lithium in medical practice.MTP Press,Lancester,pp 395–405Google Scholar
  41. Yoshida K, Smith B, Kumar R (1999) Psychotropic drugs in mothers’ milk: a comprehensive review of assay methods, pharmacokinetics and of safety of breast-feeding. J Psychopharmacol (Oxf) 13: 64–80CrossRefGoogle Scholar
  42. Zimmermann Cl, Slattery J’I’ (1983) Maintenancedose prediction based on a single determination of concentration: general applicability to two-compartment drugs with reference to lithium. J Pharmaceut Sci 72: 1262–1266CrossRefGoogle Scholar

Literatur

  1. Albrecht J (1986) Beeinflussung der Schilddrilsenfunktion und des Immunsystems durch Lithiumsalze. In:Mt H.Er-Ofrlinohausen B, Grell W (Hrsg) Die Lithiumtherapie: Nutzen, Risiko, Alternativen. Springer, Berlin Heidelberg New York Tokyo, S 276–285Google Scholar
  2. Amdlsen A (1977) Serum level monitoring and clinical pharmacokinetics of lithium. Clin Pharmacokinet 2: 73–92CrossRefGoogle Scholar
  3. Amsterdam JD, Rybakowskl J, Gottlieb J, Frazer A (1988) Kinetics of erythrocyte lithiumsodium countertransport in patients with affective illness before and during lithium therapy. J Affect Disord 14: 75–81PubMedCrossRefGoogle Scholar
  4. Avissar S, Schreiber G (1989) Muscarinic receptor subclassification and Gproteins: significance for lithium action in affective disorders and for the treatment of the extrapyramidal side effects of neuroleptics. Biol Psychiatry 26: 113–130PubMedCrossRefGoogle Scholar
  5. Avtssar S, Schreiber G, Danon A, Belmaker Rh (1988) lithium inhibits adrenergic and cholinergie increases in GTP binding in rat cortex. Nature 331: 440–442CrossRefGoogle Scholar
  6. Balla T, Dry Edi P, Hunyady L, Spat A (1984) Effects of lithium and angiotensin stimulated phosphatidylinositol turnover and aldosterone production in adrenal glomemlosa cells: a possible causal relationship. FEBS Lett 171: 179–182Google Scholar
  7. Balon R, Serct1ou R, Lycaki H, Pohl RB (1986) The effect of lithium on platelet count. Acta Psychiatr Scand 74: 474–478Google Scholar
  8. Barrat ES, Creson DL, Russell G (1968) The ef-fects of lithium salts on brain activity in the cat. Am J Psychiatry 125: 530–536Google Scholar
  9. Benkert O, Iiippius FI (1992) Psychiatrische Phai makotherapie, 5. Aufl. Springer, Berlin Heidelberg New York ‘l’okyoGoogle Scholar
  10. Berrettini WH, Nurnberger JI, Hare TA, Simmonsailing S, Gershon E S, Post Km (1983) Reduced plasma and CSF gamaminobutyric acid in affective illness: effect of lithium carbonate. Biol Psychiatry 18: 185–194PubMedGoogle Scholar
  11. Berridge MJ, Downes CP, Hanley MR (1989) Neuronal and developmental actions of lithium: a unifying hypothesis. Cell 59: 411–419PubMedCrossRefGoogle Scholar
  12. Cade JFJ (1949) Lithium salts in the treatment of psychotic excitement. ‘Vied J Aust 36: 349–352Google Scholar
  13. Van Calker D, Greil W (1986) Biochemische und zeltphysiologische Effekte von Lithiumionen.In: Mullerofrlinghausen B, Grell W (HrsgGoogle Scholar
  14. Die Lithiumtherapie. Nutzen, Risiken, Alternativen. Springer, Berlin Heidelberg New York Tokyo, S 5–34Google Scholar
  15. Campbell SS, Gillin JC, Kripke DF, Janowsky DS,Risch SC (1989) Lithium delays circadian phase of temperature and REM sleep in a bipolar depressive: a case report. Psychiatry Res 27: 23–29PubMedCrossRefGoogle Scholar
  16. Carney PA, Seggie J, Vojtechovsky M, Parker J,Grof E, Grof P (1988) Bipolar patients taking lithium have increased dark adaptation threshold compared with controls. Pharmacopsychiatry 21: 117–120PubMedCrossRefGoogle Scholar
  17. Carulli G, Azzara A, Poltoorl R, Marini A, Grassi B, Ambrogi F (1984) Effects of lithium carbonate on leukocyte functions in chronic benign neutropenia. Acta Haematol 72: 408–412PubMedCrossRefGoogle Scholar
  18. Christie JE, Whalley L J, Hunter R, Bennie J, FinkG (1989) Sulpiride treatment of acute mania with a comparison of the effects on plasma hormone concentrations of lithium and sulpiride treatment. J Affect Disord 16: 115–120PubMedCrossRefGoogle Scholar
  19. Corron FA, Wilkinson G (1975) Advanced inorganic chemistry, 3rd ed. Interscience, New YorkGoogle Scholar
  20. Dilsaver SC (1984) Lithium’s effects on muscarinic receptor binding parameters: a relationship to therapeutic efficacy? Biol Psychiatry 19: 1551–1565PubMedGoogle Scholar
  21. Dilsaver SC, Harihaiian M (1989) Chronic treat-ment with lithium produces supersensitivity to nicotine. Biol Psychiatry 25: 792–795CrossRefGoogle Scholar
  22. Domino EF, Sharp RR, Lipper S, Ballast Cl, Delidow B, Bronzo MR (1985) NMR chemistry analysis of red blood cell constituents in normal subjects and lithium-treated psychiatric patients. Biol Psychiatry 20: 1277–1283PubMedCrossRefGoogle Scholar
  23. Doukas MA, Niskanen FO, Quesenberry PJ (1985)Lithium stimulation of granulopoiesis in diffusion chambers a model of a humoral, indirect stimulation of stem cell proliferation. Blond 65: 163–168Google Scholar
  24. Drummond AH (1988) Lithium affects Gprotein receptor coupling. Nature 331:388PubMedCrossRefGoogle Scholar
  25. Emrich HM, Ullrich A, Adamczyk J, Stein R (1984) ithium affects FOG in humans. Psychiatry Res 13: 355–357PubMedCrossRefGoogle Scholar
  26. Francis RJ, Traili. MA (1970) Lithium distribution in the brains of two manic patients. Lancet ii: 523Google Scholar
  27. Friedman E, Wang H-Y (1988) Effect of chronic lithium treatment on 5 hydroxytryptamine autoreceptors and release of 5-CH) hydroxytryptamine from rat brain cortical, hippocampal, and hypothalamic slices. J Neurochem 50: 195–201PubMedCrossRefGoogle Scholar
  28. Galucchio VS (1985) Inhibition of Jimethyl soh foxideinduced Friend erythroleukemia cell differentiation in vitro by lithium chloride. Exp Cell Biol 53: 287–293Google Scholar
  29. Gailtcctiio VS (1986) Lithium stimulation of in vitro granulopoiesis: evidence for mediation via sodium transport pathways. Br J Haematol 62: 455–466CrossRefGoogle Scholar
  30. Gallicchio VS (1988) Lithium and hematopoietic toxicity. III. In vivo recovery of hematopoiesis following single-dose administration of cyclophosphamide. Acta Haematol 79: 192–197Google Scholar
  31. Gallicchio VS, Chen MG, Watts TD (1985) Lithiumstimulated recovery of granulopoiesis after sublethal irradiation is not mediated via increased levels of colony stimulating factor (CSF). Int J Radiat Biol 47: 581–590CrossRefGoogle Scholar
  32. Galucchio VS, Gambavitalo C, Watts TD, Chen MG (1986) In vivo and in vitro modulation of megakaryocytopoiesis and stromal colony formation by lithium. J Lab Clin Med 108: 199–205Google Scholar
  33. Gemba M, Tachibana A, Sugihara K, Hort M, Nakajima M (1985) Inhibitory effect of lithium on paminohippurate transport in rat kidney cortex in vitro. Renal Physiol 8: 179–188PubMedGoogle Scholar
  34. Giedke H, Pohl H (1985) Lithium suppresses hibernation in the Turkish hamster. Experientia 41: 1391–1392PubMedGoogle Scholar
  35. Girke W, Krebs FA, Mulleroerlinghausen B (1975) Effects of lithium on electromyographic recordings in man. Studies in manicdepressive patients and normal volunteers. Int Pharmacopsychiatry 10: 24–36Google Scholar
  36. Glue PW, Cowen PJ, Nutt DJ, Kolakowska T, Grahamesmith DG (1986) The effect of lithium on 5-HT-mediated neuroendocrine responses and platelet 5-FIT receptors. Psychopharmacology 90: 398–402PubMedCrossRefGoogle Scholar
  37. Gltie PW, Nlrer DJ, Cowen PJ, Broadbent D (1987) Selective effect of lithium on cognitive performance in man. Psychopharmacology 91: 109–111CrossRefGoogle Scholar
  38. Goldberg H, Clayman P, Skorecki K (1988) Mechanism of lithium inhibition of vasopressinsensitive adenylate cyclase in cultured renal epithelial cells. Am J Physiol 255 F: 995–1002Google Scholar
  39. Goodwin GM, Desouza RJ, Wood AJ, Green AR (1986) Lithium decreases 5-HT1A and 5-HT2 receptor and alpha 2 adrenoceptor mediated function in mice. Psychopharmacology 90: 482–487PubMedGoogle Scholar
  40. Gottberg E, Montreuil B, Reader TA (1988) Acute effects of lithium on dopaminergic responses: iontophoretic studies in the rat visual cortex. Synapse 2: 442–449PubMedCrossRefGoogle Scholar
  41. Gottberg E, Grondin L, Reader TA (1989) Acute effects of lithium on catecholamines, serotonin, and their major metabolites in discrete brain regions. J Neurosci Res 22: 338–345PubMedCrossRefGoogle Scholar
  42. Gror E, Brown GM, Groe P, Saxena B (1988) The effect of lithium administration on LH response in healthy volunteers. Prog Neuropsychopharmacol Biol Psychiatry 12: 263–267CrossRefGoogle Scholar
  43. Gross G, Dodt C, Hanet G (1988) Effect of chronic lithium administration on adrenoceptor binding and adrenoceptor regulation in rat cerebral cortex. Naunyn Schmiedebergs Arch Pharmacol 337: 267–272PubMedCrossRefGoogle Scholar
  44. Gudelsky GA, Koenig JI, Koyama T, Meltzer HY (1988) Activity of tubcroinfundibular dopaminergic neurons and concentrations of serum prolactin in the rat following lithium administration. Psychopharmacology 94: 92–96PubMedCrossRefGoogle Scholar
  45. Gysling K, Allard LR, Beinfeld MC (1987) Lithium preincubation stimulates the potassiuminduced release of cholecystokinin from slices of cerebral cortex and caudate-putamen incubated in vitro. Brain Res 413: 365-367PubMedCrossRefGoogle Scholar
  46. Hamburgerbar R, robert M, Newman M, Bei. Maker RH (1986) Interstrain correlation between behavioural effects of lithium and effects on cortical cyclic AMP. Pharmacol Biochem Behav 24: 9–13CrossRefGoogle Scholar
  47. Haran G, Karny N, Nachshon I (1987) Effect of lithium carbonate on lateralized cognitive functions. J Nerv Ment Dis 175: 688–691PubMedCrossRefGoogle Scholar
  48. Hart DA (1988) Lithium potentiates antigen-dependent stimulation of lymphocytes only under suboptimal conditions. Int J Tmmunopharmacol 10: 153–160CrossRefGoogle Scholar
  49. Hart DA, Groenewoud Y, Chamberland S (1986) Characterization of lithiuminduced enzyme release from human polymorphonuclear leukocytes. Biochem Cell Biol 64: 880–885PubMedCrossRefGoogle Scholar
  50. Hedgepeth CM, Conrad LJ, Zhang J, Huang HC, Lee VM, Klein PS (1997) Activation of the Wnt signaling pathway: a molecular mechanism for lithium action. Dev Biol 185: 82–91PubMedCrossRefGoogle Scholar
  51. Hegerl U (1986) Einfluss von Lithium auf die evozierten kortikalen Potentiale. Tn: Mtyt.Leroerlingiiausenb, Greil W (Hrsg) Die Lithiumtherapie. Nutzen, Risiken, Alternativen. Springer, Berlin I leidelberg New York Tokyo, S 97–105Google Scholar
  52. Hegerl U, Prochno I, Ljl.Rich G, Mt1h.Er-Oert,Tng-Hausen B (1988) Are auditory evoked potentials suitable for predicting the response to lithium prophylaxis? A study on the effects of repeated measurement, age, gender, and personality on the amplitude/stimulus intensity function in healthy volunteers. Pharmacopsychiatry 21: 336–337PubMedCrossRefGoogle Scholar
  53. Hetmar O, Nielsen M (1988) Chronic treatment with lithium chloride: reduced number of GABA receptors in frontal cortex of rat brain. Pharmacol Toxicol 62: 107–109PubMedCrossRefGoogle Scholar
  54. Heurteaux C, Baumann N, Lachapelle F, Wtssocq J-C, Thellier M (1986) Lithium distribution in the brain of normal mice and of „quaking“ dysmyelinating mutants. J Neurochem 46: 1317–1321PubMedCrossRefGoogle Scholar
  55. Hitzemann R, Mark C, Hirschowitz J, Garver D (1989) RBC lithium transport in the psychoses. Biot Psychiatry 25: 296–304CrossRefGoogle Scholar
  56. Hokin LE, Dixon JF, Los GV (1996) A novel action of lithium: stimulation of glutamate release and inositol 1, 4, 5 trisphosphate accumulation via activation of the N-methyl Daspartate receptor in monkey and mouse cerebral cortex slices. Adv Enzyme Regul 36: 229–244PubMedCrossRefGoogle Scholar
  57. Holzman PS, O’brian C, Waternaux C (1991) Effects of lithium treatment on eye movements. Biol Psychiatry 29: 1001–1015PubMedCrossRefGoogle Scholar
  58. Ikonomov OC, Manji HK (1999) Molecular mechanisms underlying mood stabilization in manicdepressive illness: the phenotype challenge. Am J Psychiatry 156: 1506–1514PubMedGoogle Scholar
  59. Joffe RT, Post RM, Ballenger JC, Rebar R, Gold PW (1986) The effects of lithium on neuroendocrine function in affectively ill patients. Acta Psychiatr Scand 73: 524–528PubMedCrossRefGoogle Scholar
  60. Johnson FN (1988) Lithium and the endocrine system. Karger, Basel (Lithium therapy monographs, vol 2Google Scholar
  61. Joseph NE, Renshaw PF, Leigh JS (1987) Systemic lithium administration alters rat cerebral cortex phospholipids. Biol Psychiatry 22: 540–544PubMedCrossRefGoogle Scholar
  62. Kadis B (1976) Inhibition of L-alanine aminotransferase by lithium salts. Bioinorg Chem 6: 183–186PubMedCrossRefGoogle Scholar
  63. Kanba S, Pfenning M, Kanba KS, Richelson E (1986) Lithium ions have a potent and selective inhibitory effect on cyclic GMP formation stimulated by neurotensin, angiotensin II and bradykinin. Eur J Pharmacol 126: 111–116PubMedCrossRefGoogle Scholar
  64. Karoum F, Koiu’l ER, Chuang L-W, Linnoila M, Wyatt RJ (1986) The effects of desipramine, zimelidine, electroconvulsive treatment and lithium on rat brain biogenic amines: a comparison with peripheral changes. Eur J Pharmacol 121: 377–385PubMedCrossRefGoogle Scholar
  65. Kasciucs WP, Mokrusch T, Korth M (1987) Early physiological effects of lithium treatment: electrooculographic and adaptometric findings in patients with affective and schizoaffective psychoses. Pharmacopsychiatry 20: 203–207CrossRefGoogle Scholar
  66. Kaschka WP, Thürauf N, Mokrusch T, Korth M (1988) Electrooculography and dark adaptation in patients with affective and schizoaffective psychoses: early physiological effects of carbamazepine and lithium. Pharmacopsychiatry 21: 404–406PubMedCrossRefGoogle Scholar
  67. Kato M, Suzuki M (1989) Effect of Li* substitution for extracellular Na* on GRF-induced GH secretion from rat pituitary cells. Am J Physiol 256C: 712–718Google Scholar
  68. Kaufman PL, Jefferson JW, Ackerman D, Baum- Gartner S (1985) Ocular effects of oral lithium in humans. Acta Ophthalmol 63: 327–332Google Scholar
  69. Kemali M, Kemali D, Lovero N, Maj M, Mittci N (1987) Lithium and melatonin: morphological modifications induced in frog retina pigment screening. Pharmacopsychiatry 20: 224–226PubMedCrossRefGoogle Scholar
  70. Kemali M, Monieleone P, Maj M, Milici N, Kemali D (1989) Lithium decreases retinal melatonin levels in the frog. Neurosci Lett 96: 235–239PubMedCrossRefGoogle Scholar
  71. Klein PS, Motor DA (1996) A molecular mechanism for the effect of lithium on development. Proc Natl Acad Sci USA 93: 8455–8459PubMedCrossRefGoogle Scholar
  72. Knight SC, ‘Iarnisii D, Scheid E, Koekebakker M, Barr RD (1989) Lithium and hydrocortisone interactions on cell growth and gene expression in human promyelocytic leukemia (HL 60). Leukemia Res 13: 289–296CrossRefGoogle Scholar
  73. Kropf D, Muller-Oerlinghausen B (1986) Effects of lithium on visual perception in manicdepressive patients without acute symptomatology. Neuropsychobiology 15: 34–42PubMedCrossRefGoogle Scholar
  74. Maarbjerg K, Vesfergaard P, Schou M (1987) Changes in serum thyroxine (T4) and serum thyroid stimulating hormone (TSH) during prolonged lithium treatment. Acta Psychiatr Scand 75: 217–221PubMedCrossRefGoogle Scholar
  75. Majerus PW, Connolly TM, Deckmyn H, Ross TS, Bross TE, Ishii H, Ransai. VS, Wilson DB (1986) The metabolism of phosphoinositidederived messenger molecules. Science 234: 1519–1526PubMedCrossRefGoogle Scholar
  76. Manji HK (1992) G Proteins: implications for psychiatry. Am J Psychiatry 149: 746–760PubMedGoogle Scholar
  77. Mami HK, Lenox RH (1999) Protein kinase C signaling in the brain: molecular transduction of mood stabilization in the treatment of manicdepressive illness. Biol Psychiatry 46:1328–1351CrossRefGoogle Scholar
  78. Manji HK, Hsiao JK, Risby ED, Oliver J, Rudorfer MV, Potier WZ (1991) The mechanisms of action of lithium. 1. Effects on serotonergic and noradrenergic systems in normal subjects. Arch Gen Psychiatry 48: 505–512PubMedGoogle Scholar
  79. Mann HK, Moore GJ, Cheng G (1999) Lithium at 50: have the neuroprotective effects of this unique cation been overlooked? Biol Psychiatry 46: 929–940CrossRefGoogle Scholar
  80. Mceachron DL, Kripke DF, Sharp FR, Lewy AJ, Mcclellan DE (1985) Lithium effects on selected circadian rhythms in rats. Brain Res Bull 15: 347–350PubMedCrossRefGoogle Scholar
  81. Menkes HA, Barabam JM, Freed AN, Snyder SH (1986) Lithium dampens neurotransmitter response in smooth muscle: relevance to action in affective illness. Proc Natl Acad Sci USA 83: 5727–5730PubMedCrossRefGoogle Scholar
  82. Michell B, Kirk C (1986) Gprotein control of inositol phosphate hydrolysis. Nature 323: 112–113PubMedCrossRefGoogle Scholar
  83. Mizuta T, Segawa T (1989) Chronic effects of imipramine and lithium on 5-HT receptor subtypes in rat frontal cortex, hippocampus, and choroid plexus: quantitative receptor auto-radiographic analysis. Jpn J Pharmacol 50: 315–326PubMedCrossRefGoogle Scholar
  84. Mork A, Geisler A (1989) Effects of GTP on hormonestimulated adenylate cyclase activity in cerebral cortex, striatum, and hippocampus from rats treated chronically with lithium. Biol Psychiatry 26: 279–288PubMedCrossRefGoogle Scholar
  85. Müller-Oerlinghausen B (1986) Wirkung von Lithiumsalzen auf Kohlenhydratstoffwechsel, Körpergewicht und gastrointestinale Funktionen. In: Mülleroerlinghausen B, Grell W (Hrsg) Die Lithiumtherapie. Nutzen, Risiken, Alternativen. Springer, Berlin Heidelberg New York Tokyo, S 297–304Google Scholar
  86. Mueller W, Brunner H, Misgeld U (1989) Lithium discriminates between muscarinic receptor subtypes on guinea pig hippocampal neurons in vitro, Neurosci Lett 100: 135–140CrossRefGoogle Scholar
  87. Odagaki Y, Nishi N, Koyama T (1997) Lack of interfering effects of lithium on receptor/G protein coupling in human platelet and rat brain membranes. Biol Psychiatry 42: 697–703PubMedCrossRefGoogle Scholar
  88. OehlerJ, Jaeiikel M, Sciimidt J (1985) Einfluss von Lithium, Carbamazepin, CaValproat und Diazepam auf isolationsbedingte Verhaltensänderungen der Maus. Biomed Biochim Acta 44: 1523–1530PubMedGoogle Scholar
  89. Osrnow DG, Pandey GN, Dams JM, Hurt SW, ‘I’osteson DC (1978) A heritable disorder of lithium transport in erythrocytes of a subpopulation of manic-depressive patients. Am J Psychiatry 135: 1070–1077Google Scholar
  90. O1-Ero-Losaua ME, Rubio MC (1985) Striatal dopamine and motor activity changes observed shortly after lithium administration. Naunyn Schmiedebergs Arch Pharmacol 330: 169–174CrossRefGoogle Scholar
  91. Pfeilschifter J, Rem¨¦ C, Dietrich C (1988) Lightinduced phosphoinositide degradation and light-induced structural alterations in the rat retina are enhanced after chronic lithium treatment. Biochem Biophys Res Commun 156: 1111–1119PubMedCrossRefGoogle Scholar
  92. Pflug B (1986) Chronobiologische Aspekte der Lithiumprophylaxe. In: MULLER-OERLINCHAUSEN B, GRELL W (Hrsg) Die Lithiumtherapie. Nutzen, Risiken, Alternativen. Springer, Berlin Heidelberg New York Tokyo, S 46–50Google Scholar
  93. Plenge P, Rafaelsen OJ (1982) Lithium effects on calcium, magnesium and phosphate in man: effects on balance, bone mineral content, faecal and urinary excretion. Acta Psychiatr Scand 66: 361–373CrossRefGoogle Scholar
  94. Poncelet M, Dangouman L, Soubrte P, Simon P (1987) Effects of neuroleptic drugs, clonidine and lithium on the expression of conditioned behavioral excitation in rats. Psychopharmacology 92: 393–397PubMedCrossRefGoogle Scholar
  95. Price LH, Charney DS, Delgado PL, Heninger GR (1989) Lithium treatment and serotonergic function: neuroendocrine and behavioral responses to intravenous Ltrytophan in affective disorder patients. Arch Gen Psychiatry 46: 1319Google Scholar
  96. Reches A, Lin KP, Karpiak SE, Faiin S, Cooper TB, Sucxow R, Jackson V, Tamir H (1985) Serotonin depletion induced by reserpine is attenuated by prophylactic administration of lithium. Eur J Pharmacol 113: 225–231Google Scholar
  97. Reisine T, Zatz M (1987) Interactions among lithium, calcium, diacylglycerides, and phorbol esters in the regulation of adrenocorticotropin hormone release from At-20 cells. J Neurochem 49: 884–889PubMedCrossRefGoogle Scholar
  98. Rem¨¦ C, Federspie lE, Pfeilschifter J, Wirz Justice A (1987) Potentiation by light of lithiuminduced retinal injury in rats. N Engl J Med 31: 1478Google Scholar
  99. Rem¨¦ CHE, Urner U, Huber CII, Busii RA, Kopp H (1991) Lithium effects in the retina: experimental and clinical observations. In: Christen Y, Doly M, Droy-Lefaix M-T (eds) Retinopathies et Neurotransmission. Les S¨¦minaires Ophtalmologiques d’IPSEN,’l’olne 3. Springer, Berlin Heidelberg New York Tokyo, pp 37–49Google Scholar
  100. Riedi. U, Barocka A, Kolem H, Demling J, Kaschka Wp, Schelp R, Stemmler M, Ebert D (1997) Duration of lithium treatment and brain lithium concentration in patients with unipolar and schizoaffective disorder a study with magnetic resonance spectroscopy. Biol Psychiatry 41: 844–850CrossRefGoogle Scholar
  101. Risby Ed, Hsiao JK, Manji HK, Bitran J, Moses F, Zhou DE, Potter WZ (1991) The mechanisms of action of lithium, II. Effects on adenylate cyclase activity and b-adrenergic receptor binding in normal subjects. Arch Gen Psychiatry 48: 512–524Google Scholar
  102. Rosenblait S, Chanley JD, Segal RL (1989) The effect of lithium on vitamin D metabolism. Biol Psychiatry 26: 206–208CrossRefGoogle Scholar
  103. Sechzerj A, Lieberman K W, Alexander G J, Weid- Man D, Stokes PE (1986) Aberrant parenting and delayed offspring development in rats ex-posed to lithium. Biol Psychiatry 21:1258–1266CrossRefGoogle Scholar
  104. Seggie J, Werstiuk ES, Josul M (1985) Lithium and twenty-four hour rhythms of serum corticosterone, prolactin and growth hormone in pigmented eye rats. Prog Neuropsychopharmacol Biol Psychiatry 9: 755–758PubMedCrossRefGoogle Scholar
  105. Seggie J, Werstiuk ES, Gro’ia L (1987) Lithium and circadian patterns of melatonin in the retina, hypothalamus, pineal and serum. Prog Neuropsychopharmacol Biol Psychiatry 11: 325–34Google Scholar
  106. Shaughnessy R, Greene SC, Pandey GN, Horns E (1985) Red-cell lithium transport and affective disorders in a multigeneration pedigree: evidence for genetic transmission of affective disorders. Biol Psychiatry 20: 451–460PubMedCrossRefGoogle Scholar
  107. Swam SP, Smith DR, Takeuchi K, Hong J-S (1987) Lithium and haloperidol differentially alter the dynorphin A (1–8) and enkephalin levels in the neurointermediate lobe of rat pituitary. Neuropeptides 10: 291–298CrossRefGoogle Scholar
  108. Sivam SP, Takeuchi K, Li S, Douglass J, Civelli O, Calvetia L, Herbert E, Mcginiy JF, Hong JS (1988) Lithium increases dynorphin A (1–8) and prodynorphin mRNA levels in the basal ganglia of rats. Mol Brain Res 3: 155–164CrossRefGoogle Scholar
  109. Smith DF (1986) Wirkung von Lithium auf die Bewegungsaktivittit von Versuchstieren. In: Muller-Oerlinghausen B, GRELL W (Hrsg) Die Lithiumtherapie. Nutzen, Risiken, Alternativen. Springer, Berlin Heidelberg New York Tokyo, S 51–59Google Scholar
  110. Smith DF (1988) Lithium attenuates clonidineinduced hypoactivity: further studies in inbred mouse strains. Psychopharmacology 94: 428–430Google Scholar
  111. Stengaardpedersen K, Salon M (1985) Opioid peptides and receptors in relation to affective illness. Effects of desipramine and lithium on opioid receptors in rat brain. Acta Pharmacol ‘l’oxicol 56 1Suppl 11: 170–179Google Scholar
  112. Storlien LH, Higson FM, Gleeson RM, Smythe GA, Atrens DM (1985) Effects of chronic lithium, amitriptyline and mianserin on glucoregulation, corticosterone and energy balance in the rat. Pharmacol Biochem Behav 22: 119–125PubMedCrossRefGoogle Scholar
  113. Swann AC, Koslow SH, Katz M, Maas LW, Javaid J, Secu Nna SK, Rois W S E (1987) Lithium carbonate treatment of mania. Cerebrospinal fluid and urinary monoamine metabolites and treatment outcome. Arch Gen Psychiatry 44: 345-354PubMedGoogle Scholar
  114. Terhaag B, Sch Leber A, Schaps P, Winkler II (1978) The distribution of lithium into cerebrospinal fluid, brain tissue and bile in man. Int J Clin Pharmaco116: 333–335Google Scholar
  115. Thornhill DP (1981) The biological disposition and kinetics of lithium. Biopharm Drug Dispos 2: 305–332PubMedCrossRefGoogle Scholar
  116. Thürauf N, Kasciika WP (1991) Functional and morphological effects of lithium treatment on structures of the eye and oculomotor systems. Eur J Psychiatry 5: 47–54Google Scholar
  117. Ullricii A(1986)Tierexperimentelle neurophysiologische Untersuchungen zur Lithiumwirkung.In: Mutteroer I,Inghausen B, Greit W (Hrsg) Die Lithiumtherapie.Nutzen,Risiken, Alternativen.Springer, Berlin Heidelberg New York Tokyo,S 35–45Google Scholar
  118. Ullrich A, Adamczyk J, Zihl J, Emrich HM (1985) Lithium effects on ophthalmological-electrophysiological parameters in young healthy volunteers. Acta Psychiatr Scand 72: 113–119PubMedCrossRefGoogle Scholar
  119. Ulricii G (1986) Neurophysiologische Aspekte der Lithiumwirkung. In: M H.Leroerlinghausen B, Greil W (Hrsg) Die Lithiumtherapie. Nutzen, Risiken, Alternativen. Springer, Berlin Heidelberg New York Tokyo, S 78–96Google Scholar
  120. Weingartner H, Rudorfer MV, Linnoila M (1985) Cognitive effects of lithium treatment in normal volunteers. Psychopharmacology 86: 472–474PubMedCrossRefGoogle Scholar
  121. Werstiuk ES, Katiibone MP, Gror P (1984) Erythrocyte lithium efflux in bipolar patients and control subjects: the question of reproducibility. Psychiatry Res 13: 175–185PubMedCrossRefGoogle Scholar
  122. Wilkinson M, Joshi M, Werstiuk ES, Seggie J (1987) Lithium and rhythms of betaadrenergic ((3H)CGP-12177) binding in intact rat retina, pineal gland, and hypothalamus. Biol Psychiatry 22: 1191–1200PubMedCrossRefGoogle Scholar
  123. WissocqJC, Heurteaux C, Hennequin E, Thellier M (1985) Microlocating lithium in the mouse embryo by use of a (n, alpha) nuclear reaction. Roux’s Arch Dev Biol 194: 433–435CrossRefGoogle Scholar
  124. Wood AI, Elphick M, Ai1enson JK, Grahame.Smi’t’h DG (1989) The effect of lithium on cation transport measured in vivo in patients suffering from bipolar affective illness. Br J Psychiatry 155: 504–510PubMedCrossRefGoogle Scholar
  125. Wood K, Swade C, Aboli-Saler Mt, Coppen A (1985) Apparent supersensitivity of platelet 5-H’l’ receptors in lithium-treated patients. J Affect Disord 8: 69–72PubMedCrossRefGoogle Scholar
  126. Zatz M, Retsine TD (1985) Lithium induces corticotropin secretion and desensitization in cultured anterior pituitary cells. Proc Natl Acad Sei USA 82: 1286–1290CrossRefGoogle Scholar

Literatur

  1. Berggren U (1987) Effects of shortterm lithium administration on tryptophan levels and 5-hydroxytryptamine synthesis in whole brain and brain regions in rats. J Neural Transm 69: 115–121PubMedCrossRefGoogle Scholar
  2. Berrettini WEI, Nurnberger JI, Scheinin M, Serra-La T, Linnoilam, Narrow W, Simmons-Ailing S, Gershon ES (1985) Cerebrospinal fluid and plasma monoamines and their metabolites in euthymic bipolar patients. Biol Psychiatry 20: 257–269Google Scholar
  3. Blier P, DeMontigny C (1985) Short-term lithium administration enhances serontonergic neurotransmission: electrophysiological evidence in the rat CNS. Eur J Pharmacol 113: 69–77PubMedCrossRefGoogle Scholar
  4. Blier P, De Montigny C, Tardif D (1987) Shortterm lithium treatment enhances responsiveness of postsynaptic 5-HT, receptors without altering 5-HT autoreceptor sensitivity: an elec, trophysiological study in the rat brain. Synapse 1: 225–232PubMedCrossRefGoogle Scholar
  5. Born Gvr, Grignani G, Martin K (1980) Longterm effect of lithium on the uptake of 5 hyclroxytryptamine by human platelets. Br J Clin Pharmacol 9: 321-325PubMedGoogle Scholar
  6. Collard KJ (1976) The effect of chronic lithium administration on stimulation-induced changes in forebrain 5 hydroxyindolos: modification by chlorimipramine. Br J Pharmacol 57: 445Google Scholar
  7. Coppen A, Swade C, Wood K (1980) Lithium restores abnormal platelet 5-HT transport in patients with affective disorders. Br J Psychiatry 136: 235–238PubMedCrossRefGoogle Scholar
  8. De Montignv C (1994) Lithium addition in treatment-resistant depression. Int J Psychopharmacol 9 [Suppl 2]: 31–35CrossRefGoogle Scholar
  9. Elphick M, Yang J-D, Cowen PJ (1990) Effects of carbamazepine on dopamine-and serotoninmediated neuroendocrine responses. Arch Gen Psychiatry 47: 135–140PubMedGoogle Scholar
  10. Franke L, Schewe H-J, Müller B, Campman V, Kitzrow W, Uebelhack R, Thiesflechtner K, Berghöfer A, Mülleroerlinghausen B (2000) Serotonergic platelet variables in un-medicated patients suffering from major depression and healthy subjects. Life Sei 67: 301–305CrossRefGoogle Scholar
  11. Friedman E, Wang H-Y (1987) Effect of chronic lithium treatment on 5-hydroxytryptamine autoreceptors and release of 5-(3H)hydroxytryptamine from rat brain cortical, hippocampal, and hypothalamic slices. J Neurochem 50: 195–201CrossRefGoogle Scholar
  12. Exit B, Peterson U, Sedvall G (1975) The effect of lithium treatment on manic symptoms and levels of monoamine metabolites in cerebrospinal fluid of manic depressive patients. Psychopharmacologia 44: 99–103CrossRefGoogle Scholar
  13. Glue PW, Cowen PJ, Nun DJ, Kol Kowska T, Grahamesmith DG (1986) The effect of lithium on 5-HTmediated neuroendocrine responses and platelet 5-HT receptors. Psychopharmacology 90: 398–402PubMedCrossRefGoogle Scholar
  14. Goodnick PJ, Arora RC, Jackman H, Meltzer HY (1984) Neurochemical changes during discontinuation of lithium prophylaxis. II. Alterations in platetelet serotonin function. Biol Psychiatry 19: 891–897PubMedGoogle Scholar
  15. Goodwin GM, De Souza RJ, Wood AJ, Green AR (1986a) The enhancement by lithium of the 5-HTAmediated serotonin syndrome produced by 8-OH-DPAT in the rat: evidence for the post-synaptic mechanism. Psychopharmacology 90: 488–493Google Scholar
  16. Goodwin GM, De Souza RJ, Wool AJ, Green AR (1986b) Lithium decreases 5-HTIAand 5-HT2 receptor and alpha-2-adrenoreceptor mediated function in mice. Psychopharmacology 90: 482–487Google Scholar
  17. Harrison-Read PE (1986) Chronic lithium treatment in rats has different effects on motor responses mediated by 5-HT, and 5-HT2 receptors. Br J Pharmacol 87: 219Google Scholar
  18. Hegeri, U, Ulrich G, Mülleroerlinghausen B (1987) Auditory evoked potentials and response to lithium prophylaxis. Pharmacopsychiatry 20: 213–216CrossRefGoogle Scholar
  19. Hegerl U, Herrmann WM, Ulrich G, Ímülleroerlinghausen B (1990) Effects of lithium on auditory evoked potentials in healthy subjects. Biol Psychiatry 27: 555–560PubMedCrossRefGoogle Scholar
  20. Ilorra I, Yamawaki S (1986) Lithium decreases 5-HT1receptors but increases 5-HT sensitive adenylate cyclase activitry in rat hippocampus. Biol Psychiatry 21: 1382–1390CrossRefGoogle Scholar
  21. Hotta I, Yamawaki S, Segawa T (1986) Long-term lithium treatment causes serotonin receptor downregulation via serotonergic presynapses in rat brain. Neuropsychobiology 16: 1926CrossRefGoogle Scholar
  22. Johnson FN (1984) The psychopharmacology of lithium. MacMillan, London KNAPP S (1983) Lithium. In: Graha_Me-Smith Dg, Hippius H, Winokur G (eds) Psychopharmacology 1 ¡ª a biennial critical survey of the international literature, part 1. Preclinical psychopharmacology. Excerpta Medica, Amsterdam Oxford Princeton, pp 71–106Google Scholar
  23. Kropf D (1980) Probleme und Konzepte der LithiumForschung aus psychologischer Sicht. Pharmakopsychiatrie 13: 168–174Google Scholar
  24. Kropf D (1986) Der psychologische Zugang zur Prophylaxe akuter affektiver Psychosen mit Lithiumsalzen. In: Mülleroerlingiialisen B (Hrsg) Die Lithiumtherapie Nutzen, Risiken, Alternativen. Springer, Berlin Heidelberg New York Tokyo, S 60–77Google Scholar
  25. Kropf D, Mülleroerlinghausen B (1985) Assess-ment of visual perception by means of the signal detection theory in patients under Lithium long-term treatment. Pharmacopsychiatry 18: 102–103CrossRefGoogle Scholar
  26. Malmgren R, Abergwisredt A, Eneroth P (1991) Lithium interferes with seasonal modulation of platelet serotonin uptake in depression. Lithium 2: 149–153Google Scholar
  27. Mannel M, Mülleroerlinghausen B, Czernik A, Sauer H (1997) 5-HT brain function in affective disorder: d,1-fenfluramine-induced hormone release and clinical outcome in long-term lithium/carbamazepine prophylaxis. J Affect Disord 46: 101–113PubMedCrossRefGoogle Scholar
  28. Mccancekatz E, Price LH, Charney DS, Iientnger GR (1992) Serotonergic function during lithium augmentation of refractory depression. Psychopharmacol 108: 93–97CrossRefGoogle Scholar
  29. Mekler G, Woggon B (1997) A case of serotonin syndrome caused by venlafaxine and lithium. Pharmacopsychiatry 30: 272–273PubMedCrossRefGoogle Scholar
  30. Meltzer HY, Lowy MT (1987) The serotonin hypothesis of depression. In: Meltzer HY (ed) Psychopharmacology. Raven Press, New York, pp 513-523Google Scholar
  31. Meltzer HY, Arora RC, Goodnick P (1983) Effect of lithium carbonate on scrotonin uptake in blood platelets of patients with affective disorders. J Affect Disord 5: 215–221PubMedCrossRefGoogle Scholar
  32. Meltzer HY, Lowy M, Robertson A, Goodnick P, Perline R (1984) Effect of 5-hydroxytryptophan on serum cortisol levels in major affective disorders. III. Effect of antidepressants and lithium carbonate. Arch Gen Psychiatry 41: 391–397PubMedGoogle Scholar
  33. Mühlbaler HD (1985) Human aggression and the role of central serotonin. Pharmacopsychiatry 18: 218–221CrossRefGoogle Scholar
  34. Mühlbauer HD, Mülleroerlinghausen B (1985) Fenfluramine stimulation of serum cortisol in patients with major affective disorders and healthy controls: further evidence for a central serotonergic action of lithium in man. J Neural Transm 61: 81–94PubMedCrossRefGoogle Scholar
  35. Mülleroerlinghausen B (1985) Lithium longterm treatment does it act via serotonin? Pharmacopsychiatry 18: 214–217CrossRefGoogle Scholar
  36. Mülleroerlunghausen B (1987) Mental functioning. In: Johnson FN (ed) Depression and mais. Modern lithium therapy. IRI. Press, Oxford Washington DC, pp 246–252Google Scholar
  37. Mülleroerlinghausen B, Umbach C, Hegerl U, Volk J (1988) Endokrinologische und psychophysiologische Befunde bei LithiumRespondern und Nonrespondern. In: Beckmann H, Laux G (Hrsg) Biologische Psychiatrie. Synopsis 1986/87. Springer, Berlin Heidelberg New York Tokyo, S 281–283Google Scholar
  38. Odagaki Y, Koyania T, Yamashita I (1992) T.ithiuM and serotonergic neutral transmission: a review of pharmacological and biochemical aspects in animal studies. Lithium 3: 95–107Google Scholar
  39. Poirier MF, Galzin AM, Plmoule C, Schoemaker H, Le Quan Bei KH, Meyer P, Gay C, Loo H, Langer SZ (1988) Short-term lithium administration to healthy volunteers produces long-lasting pronounced changes in platelet serotonin uptake but not imipramine binding. Psychopharmacology 94: 521–526PubMedCrossRefGoogle Scholar
  40. Post RM (1990) Sensitization and kindling perspectives for the course of affective illness: toward a new treatment with the anticonvulsant carbamazepine. Pharmacopsychiatry 23: 3–17PubMedCrossRefGoogle Scholar
  41. Post RM, Weiss SRB (1998) Sensitization and kindling phenomena in mood, anxiety, and obsessive-compulsive disorders: the role of serotonergic mechanisms in illness progression. Biol Psychiatry 44: 193–206PubMedCrossRefGoogle Scholar
  42. Power AC, Dorkins CE, Cowen PJ (1993) Effect of lithium on the prolactin response to dfenfluramine in healthy subjects. Biol Psychiatry 33: 801–805PubMedCrossRefGoogle Scholar
  43. Price LH, Charney DS, Delgado PL, Heninger GR (1989) Lithium treatment and serotonergic function: neuroendocrine and behavioral responses to intravenous L-nyptophan in affective disorder patients. Arch Gen Psychiatry 46: 13–19PubMedGoogle Scholar
  44. Pricf LH, Charney DS, Delgado PL, Heninger GR (1990) Lithium and serotonin function: implications for the serotonin hypothesis of depression. Psychopharmacology 100:3–12Google Scholar
  45. Sangdee C, Franz DN (1980) Lithium enhancement of central 5-FIT transmission induced by 5-HT precursors. Biol Psychiatry 15: 59–75PubMedGoogle Scholar
  46. Scout M, Reading HW, London JB (1979) Studies on human blood platelets in affective disorder. Psychopharmacology 50: 131–135CrossRefGoogle Scholar
  47. Slater S, De La Vega CE, Skyler I, Murphy DL (1976) Plasma prolactin stimulation by fenfluramine and amphetamine. Psychopharmacol Bull 12: 26–27PubMedGoogle Scholar
  48. Sobanski T, Bagli M, Laux G, Rao ML (1997) Serotonin syndrome after lithium addon medication to paroxetinc. Pharmacopsychiatry 30: 106–107PubMedCrossRefGoogle Scholar
  49. Swann AC, Iieninger GR, Roth RH, Maas j V(1981) Differential effects of short-and longterm lithium on tryptophan uptake and serotonergic function in cat brain. Life Sei 28: 347–354CrossRefGoogle Scholar
  50. Tiiiesflechtner K, Weigel I, Mülleroerlinghausen B (1994) 5-HT uptake in platelets of lithiumtreated patients with affective disorders and of healthy controls. Pharmacopsychiatry 27 [Suppll]: 4–6CrossRefGoogle Scholar
  51. Treiser S, Kellar KJ (1980) Lithium: effects on serotonin receptors in rat brain. Eur J Pharmacol 64: 183–185PubMedCrossRefGoogle Scholar
  52. Treiser SL, Cascio CS, O`Donohue TL, Tiioa NB, Jaconowitz DM, Keli,AR KJ (1981) Lithium increases serotonin release and decreases serotonin receptors in the hippocampus. Science 213: 1529–1531PubMedCrossRefGoogle Scholar
  53. Ulrich G, Frick K, Stieglitz RD, Mülleroerlinghaoeen B (1987) Tnterindividual variability of lithium-induced EEG changes in healthy volunteers. Psychiatry Res 20: 117–127PubMedCrossRefGoogle Scholar
  54. Ulrich G, Herrmann WM, Heger’, U, Mulleroerlinghausen B (1990) Effect of lithium on the dynamics of clectrocncephalographic vigilance in healthy subjects. J Affect Disord 20: 19–25PubMedCrossRefGoogle Scholar
  55. Van Praag HM (1977) Significance of biochemical parameters in the diagnosis, treatment, and prevention of depressive disorders. Biol Psychiatry 12: 101–131Google Scholar
  56. Van Praag HM, Dr Haan S (1979) Central serotonin metabolism and frequency of depression. Psychiatry Res 1: 219–224PubMedCrossRefGoogle Scholar
  57. Wajda IJ, Banayschwartz M, Manigault I, Lajtha A (1986) Modulation of the serotonin S2-receptor in brain after chronic lithium. Neurochem Res 11 (7): 949–957PubMedCrossRefGoogle Scholar
  58. Waldmeier Pc (1987) Is there a common denominator for the antimanic effect of lithium and anticonvulsants? Pharmacopsychiatry 20: 3747CrossRefGoogle Scholar
  59. Walsh AE, Ware CJ, Cowen PJ (1991) Lithium and 5-HT IA receptor sensitivity: a neuroendocrine study in healthy volunteers. Psychopharmacology 105: 568–572PubMedCrossRefGoogle Scholar
  60. Wang H Y, Friedman E (1988) Chronic lithium: desensitization of autoreceptors mediating serotonin release. Psychopharmacology 94: 312–314PubMedGoogle Scholar
  61. Winkler N (1993) Endokrine Reaktionen als Ausdruck zentraler serotonerger Aktivität nach FenfluraminStimulation bei Lithium-behandelten und unbehandelten Patienten und Probanden. Dissertation, Freie Universität BerlinGoogle Scholar

Literatur

  1. Ahlpors UG, Baasrrup PC, Drvckfrr SJ et al. (1981) Flupenthixol decanoate in recurrent manicdepressive illness. A comparison with lithium. Acta Psychiatr Scand 64: 226–237CrossRefGoogle Scholar
  2. Albrecht J (1986a) Beeinflussung der Schilddrüsenfunktion und des Immunsystems durch Lithiumsalze. Tn: mülierofrijnghausen b, greb. W (Hrsg) Die Lithiumtherapie: Nutzen, Risiken, Alternativen. Springer, Berlin Heidelberg New York Tokyo, S 276_285Google Scholar
  3. Albrecht G (1986b) Unerwünschte Wirkungen der Lithiumtherapie an der Haut. In: MÜLLEROERLTNGIIAUSEN B, GREIL W (Hrsg) Die Lithiumtherapie: Nutzen, Risiken, Alternativen. Springer, Berlin Heidelberg New York Tokyo, S 305–315Google Scholar
  4. Allon M, Pasque CB, Rodriguez M (1990) Interaction of captopril and ibuprofen on glomerular and tubular function in humans. Am J Physiol 259: F 233–238Google Scholar
  5. Amdisen A (1988) Clinical features and management of lithium poisoning. Med Toxicol Adverse Drug Exp 3: 18–32PubMedGoogle Scholar
  6. Amsterdam JD, 1viaislin G, Potter L, Giountoli R, Kontowsk LH (1991) Suppression of recurrent genital herpes infections with lithium carbonate: a randomized, placebo-controlled trial. Lithium 2: 17–25Google Scholar
  7. Angst J (1981) Ungelöste Probleme bei der Indikationsstellung zur Lithiumprophylaxe affektiver und schizoaffektiver Erkrankungen. In: Berner P et al. (eds) Current perspectives in lithium prophylaxis. Karger, Basel, pp 32–44 (Bibliotheca Psychiat, vol 161Google Scholar
  8. Apte SN, Langston JW (1983) Permanent neurological deficits due to lithium toxicity. Ann Neurol 13: 453–455PubMedCrossRefGoogle Scholar
  9. Austin LS, Arana GW, Melvin JA (1990) Toxicity resulting from lithium augmentation of antidepressant treatment in elderly patients. J Clin Psychiatry 51: 344–345PubMedGoogle Scholar
  10. Austin M-PV (1992) Puerperal affective psychosis: is there a case for lithium prophylaxis? Br J Psychiatry 161: 692–694PubMedCrossRefGoogle Scholar
  11. Baastrup PC, Poulsen JC, Schou M, Thomsen K, Amdisen A (1970) Prophylactic lithium: double blind discontinuation in manicdepressive and recurrent-depressive disorders. Lancet ii: 326–330Google Scholar
  12. Bailine SH, Doer M (1986) Neurotoxicity induced by combined lithium-thioridazin treatment. Biol Psychiatry 21: 834–837PubMedCrossRefGoogle Scholar
  13. Bartheimebs M, Alttebachrr M, Madonna O, Grima M, Imbs JL (1995) Absence of a losartan inter-action with renal lithium excretion in the rat. Br J Pharm 4: 2166–2169Google Scholar
  14. Bauer M (1997) Behandlung der akuten Depression mit Lithium. In: Milleroerlingiiausen B, Greil W, Berghöffr A (Hrsg) Die Lithiumtherapie. Nutzen, Risiken, Alternativen, 2. Aufl. Springer, Berlin Heidelberg New York Tokyo, S 178–189Google Scholar
  15. Baumann P, Ni:. R, Souche A, Monta: dl S, Baettig D, Lambert S, Uehlinger C, Kasas A, Amey M, Jonzierperey M (1996) A double-blind, placebocontrolled study of citalopram with and without lithium in the treatment of therapyresistant depressive patients: a clinical, pharmacokinetic, and pharmacogenetic investigation. J Clin Psychopharmacol 16: 307–314PubMedCrossRefGoogle Scholar
  16. Baxter LR (1985) Can lithium carbonate prolong the antidepressant effect of sleep deprivation? Arch Gen Psychiatry 42: 635PubMedGoogle Scholar
  17. Baxter Lr JR, L¨ªion EH, Schwartz JM, Altshuler LL, Wilkins JN, Richeimer S, Guze BH (1986) Prolongation of the antidepressant response to partial sleep deprivation by lithium. Psychiatry Res 19: 17–23PubMedCrossRefGoogle Scholar
  18. Bellomo R, Kearly Y, Parkin G, Love J, Boyce N (1991) Treatment of life-threatening lithium toxicity with continuous arterio-venous hemodiafiltration. Grit Care Med 19: 836-837CrossRefGoogle Scholar
  19. Brndz H, Feinberg M (1984) Aspirin increases serum lithium ion levels. Arch Gen Psychiatry 41: 310–311Google Scholar
  20. Beroh¨®fer A (1997) Wirkung von Lithium auf Schwangerschaft und Sexualität. In: Mi’lleroerlingiiausen B, Greil W, Berghöfer A (HrsgGoogle Scholar
  21. Die Lithiumtherapie. Nutzen, Risiken, Alternativen, 2. Aufl. Springer, Berlin Heidelberg New York Tokyo, S 413–423Google Scholar
  22. Beer P, De Montigny C, Chalut Y (1987) Modifications of the serotonin system by antidepressant treatments: implications for the therapeutic response in major depression. j Clin Psychopharmacol 7: 24–35CrossRefGoogle Scholar
  23. Bocchetta A, Bernardi F, Burrai C, Pedditzi M, Lovisri I.I A, Velluzzi F, Martino E, Del Zompom (1992)1’he course of thyroid abnormalities during lithium treatment: a two-year follow-up study. Acta Psychiatr Scand 86: 38–41CrossRefGoogle Scholar
  24. Bouman TK, Niemantsverdrietvan Kampen JG, Ormel J, Slooff CJ (1986) The effectiveness of lithium prophylaxis in bipolar and unipolar depressions and schizo-affective disorders. J Affect Disord 11: 275–280PubMedCrossRefGoogle Scholar
  25. Bovril WF, Feighner JP (1991) Pharmacokinetics and drug interactions. In: Feighner J P, Boyer Wf (eds) Selective serotonin re-uptakte inhibitors. Wiley, Chichester, pp 81–88Google Scholar
  26. Bratfos O, I Lang JO (1968) The course of manic-depressive psychosis. Acta Psychiatr Scand 44: 89–112PubMedCrossRefGoogle Scholar
  27. Bsciior T (1999) Complete suppression of recurrent herpes labialis with lithium carbonate. Pharmacopsychiat 32: 158CrossRefGoogle Scholar
  28. Bucht G, Wahlin A (1978) Impairment of renal concentrating capacity by lithium. Lancet i: 789Google Scholar
  29. Byrd GJ (1977) Lithium carbonate and methyl-dopa: apparent interaction in man. Clin Toxicol 11: 1–4PubMedCrossRefGoogle Scholar
  30. Cade JFJ (1949) Lithium salts in the treatment of psychotic excitement. Med J Aust 36: 349–352Google Scholar
  31. Camacho Pulido JA, Rucabado Aguilar L, Estecha Foncea MA, Quesada Blanca JL, Lara B, Ji.Menez Sanchez JM (1995) Shock e hipoxemia severa en intoxicacion por litio. Farmacia Clinica 12: 509–510Google Scholar
  32. Chamberlain S, Hahn PM, Casson P, Reir RL (1990) Effect of menstrual cycle phase and oral contraceptive use on serum lithium levels after a loading dose of lithium in normal women. Am J Psychiatry 147: 907–909PubMedGoogle Scholar
  33. Chaudry RP, Waters BGH (1983) Lithium and carbamazepine interaction. J Clin Psychiatry 44: 30–31Google Scholar
  34. Cohen WH, Cohen NH (1974) Lithium carbonate, haloperidol and irreversible brain damage. J Am Med Assoc 230: 1283–1287CrossRefGoogle Scholar
  35. Coppen A, Noguera R, Bailey J, Burns BH, Swani MS, Hare EH, Gardner R, Magos R (1971) Prophylactic lithium in affective disorders. Lancet ii: 275–279Google Scholar
  36. Copper A, Montgomery SA, Gi.Pta RK, Bailey JE (1976) A doubleblind comparison of lithium carbonate and maprotiline in the prophylaxis of the affective disorders. Br J Psychiatry 128: 479–485CrossRefGoogle Scholar
  37. Coppen A, Ghose K, Rao R, Bailey J, Peet M (1978) Mianserin and lithium in the prophylaxis of depression. Br J Psychiatry 133: 206–210PubMedCrossRefGoogle Scholar
  38. Corbeit JJ, Jacobson DM, Tiiompson HS, Hart MN, Albert DW (1989) Downbeating nystagmus and other ocular motor defects caused by lithium toxicity. Neurology 39: 481–487Google Scholar
  39. Correa F, Eiser A (1992) Angiotensin converting enzyme inhibitors and lithium toxicity. Am J Med 93: 108–109PubMedCrossRefGoogle Scholar
  40. Cournoyerg DF,Monttgny C, Ouellettrj, I, Eblanc G, Langlois R, Elie R (1984) Lithium addition in tricyclicresistant unipolar depression: a placebocontrolled study. Col legium Internationale Neuropsychopharmacologicum, Florence, Italy, June 19–23Google Scholar
  41. Cindall RL, Brooks PW, Murray LG (1972) A controlled evaluation of lithium prophylaxis in affective disorders. Psychol Med 2: 308–311CrossRefGoogle Scholar
  42. Delgado PL, Price LIT, Ci Arney DS, Heninger GR (1988) Efficacy offluvoxamine in treatment-refractory depression. J Affect Disord 15: 55–60PubMedCrossRefGoogle Scholar
  43. De Monttgny C (1994) Lithium addition in refractory depression. In: Nolen Wa, ZOHARJ, Roose SP, AMSTERDA.MJD (eds) Refractory depression: current strategies and future directions. Wiley, Chichester, pp 47–57Google Scholar
  44. De Montigny C, Grunberg F, Mayer A, Deschenes JP (1981) Lithium induces rapid relief of depression in tricyclic antidepressant drug non-responders. Br J Psychiatry 138: 252–256PubMedCrossRefGoogle Scholar
  45. De Montigny C, Cournoyer G, Morissette R (1983) Lithium carbonate addition in tricyclic antidepressant resistant unipolar depression. Correlations with the neurobiologie actions of tricyclic antidepressant drug and lithium ac-tion on the serotonin system. Arch Gen Psychiatry 40: 1327–1334PubMedGoogle Scholar
  46. Dinan TG, Barry S (1989) A comparison of electroconvulsive therapy with a combined lithium and tricyclic combination among depressed tricyclic nonresponders. Acta Psychiatr Scand 80: 97–100PubMedCrossRefGoogle Scholar
  47. Dolle W, MullerOerlingiiausen B, Scfiwabe U (1986) Kombinationstherapie and Multimedikation. In: Dolle W, Miilleroeritnghaiisen B, Schwabe U (Hrsg) Grundlagen der Arzneimitteltherapie, Entwicklung, Beurteilung and Anwendung von Arzneimitteln. Bibliographisches Institut, MannheimGoogle Scholar
  48. Dousryblazy P, Rosnn M, Livared B (1986) Angiotensin converting enzyme inhibitors and lithium treatment. Lancet is 14–48Google Scholar
  49. Donner DL, Stallone F, Sieve RR (1976) Lithium carbonate and affective disordes.. V. A double-blind study of prophylaxis of depression in bipolar illness. Arch Gen Psychiatry 33: 117–120Google Scholar
  50. Duplis RE, Coopr:R AA, Rosamond LJ, Campbellbright S (1996) Multiple delayed peak lithium concentrations following acute intoxication with an extendedrelease product. Ann Pharmacother 30: 356–360Google Scholar
  51. Ebert D, Jaspert A, Murata II, Kaschka WP (1995) Initial lithium augmentation improves the antidepressant effects of standard TCA treatment in nonresistant depressed patients. Psychopharmacology 118: 223–225PubMedCrossRefGoogle Scholar
  52. Et. Mallakh RS (1988) Complications of concurrent lithium and electroconvulsive therapy: a review of clinical material and theoretical considerations. Biol Psychiatry 23: 595–601CrossRefGoogle Scholar
  53. Emiich HM (1986) Alternativen zur Lithiumprophylaxe. In: Mlli.P:Roerlinghalsen B, Greil W (Hrsg) Die Lithiumtherapie. Nutzen, Risiken, Alternativen. Springer, Berlin Heidelberg New York Tokyo, S 356–368Google Scholar
  54. Endicott j, sptter rt., fleiss jl, cohen j (1976) The global assessment scale: a procedure for measuring overall severity of psychiatric disturbance. Arch Gen Psychiatry 33: 766–771Google Scholar
  55. Engelhardt A, Neondôrfp:R B (1988) Downbeat-Nystagmus bei Lithiummedikation. Nervenarzt 59: 624–627PubMedGoogle Scholar
  56. Epstein RS (1989) Wernicke’s encephalopathy following lithiuminduced diarrhea. Am J Psychiatry 146: 806–807PubMedGoogle Scholar
  57. Falk WE, Mahnke MW, Poskanzer DC (1979) Lithium prophylaxis of corticotropininduced psychosis. J Am Med Assoc 241: 1011–1012CrossRefGoogle Scholar
  58. Farag S, Watson RDS, Honeybourne D (1994) Symptomatic junctional bradycardia due to lithium intoxication in patient with previously normal electrocardiogram. Lancet 343: 13–71Google Scholar
  59. Faya M, Rosenbaum JF, Mccrath PJ, Stewart JW, Amsterdam JD, Quitkin FM (1994) Lithium and tricyclic augmentation of fluoxetine treatment for resistant major depression: a doubleblind, controlled study. Am J Psychiatry 151: 1372–1374Google Scholar
  60. Feighner Jp, Robins E, Guze Sb, Woodruff Ra, Winokur G, Munoz R (1972) Diagnostic criteria for use in psychiatric research. Arch Gen Psychiatry 26: 57–63PubMedGoogle Scholar
  61. Ferberta, CZERNTK A (1987) Persistierendes Kleinhirnsyndrom nach LithiumIntoxikation. Nervenarzt 58: 764–770Google Scholar
  62. Fieve RR, Dunner DL, Kumbarachi T et al. (1976) Lithium carbonate prophylaxis of depression in three subtypes of primary affective disorder. Pharmacopsychiatry 9: 100–107CrossRefGoogle Scholar
  63. Follezou J, Bleisel J (1985) Reduction of temperature and lithium poisoning. N Engl J Med 313: 1609PubMedGoogle Scholar
  64. Franchini L, Zanardi R, Smeraldi E, Gasperini M (1999) Early onset of lithium prophylaxis as a predictor of good long term outcome. Eur Arch Psychiatry Clin Neurosci 249: 227–230PubMedCrossRefGoogle Scholar
  65. Friedman BC, Bekes CE, Scott WE, Barttfr T (1992) ARDS following acute lithium carbonate intoxication. Intensive Care Med 18: 123–124PubMedCrossRefGoogle Scholar
  66. Flinakubo T, Nakamura T, Kimura Y, Kanayama R, Ohki M, Sano R, Koiice Y (1991) A case of acute lithium intoxication. Neurootological findings. Practica Otologica Kyoto O [Suppl] 511: 187–191Google Scholar
  67. Gabriel E, Karobath M, Lenz G (1976) Extrapyramidale Symptomatik bei Kombination der LithiumLangzeittherapie mit Nortriptylin. Nervenarzt 47: 46–48PubMedGoogle Scholar
  68. Garbut JC, Mayo JP, Gilette GM, Little KY, Mason GA (1986) Lithium potentiation of tricyclic antidepressants following lack of T3 potentiation. Am J Psychiatry 143: 1038–1039Google Scholar
  69. Garcia G, Crismon ML, Dorson PG (1994) Seizures in two patients after the addition of lithium to a clozapine regimen. J Clin Psychopharmacol 14: 426–427PubMedGoogle Scholar
  70. Gelenberg AJ, Kane JM, Keller MB, Lavotu P, Rosenbaum JF, Cole K, Lavelle J (1989) Comparison of standard and low serum levels of lithium for maintenance treatment of bipolar disorder. N Engl J Med 321: 1489–1493PubMedCrossRefGoogle Scholar
  71. Gerdes H (1978) Symptomatologie und Therapie der Lithiumintoxikation. Internist 19: 252–254Google Scholar
  72. Ghadirian AM, Annable L, Bei.Anger MC (1992) Lithium, benzodiazepines, and sexual function in bipolar patients. Am J Psychiatry 149: 801–805PubMedGoogle Scholar
  73. Glen AIM, Donn M, Hulme EB, Kreitman N (1979) Mortality of lithium. Neuropsychobiology 5: 167–173PubMedCrossRefGoogle Scholar
  74. Glen AIM, Johnson AL, Shepherd M (1984) Continuation therapy with lithium and amitriptyline in unipolar depressive illness: a randomized, double-blind, controlled trial. Psychol Med 14: 37–50PubMedCrossRefGoogle Scholar
  75. Goddard J, Bloom SR, Frackowiak RSJ, Pusey CD, Macdermar J, Liddle PF (1991) Lithium intoxication. Br Med J 302: 1267–1269Google Scholar
  76. Granoff AL, Davis JM (1978) Heat illness syndrome and lithium intoxication. J Clin Psychiat 39: 103–107Google Scholar
  77. Green ST, Dunn FG (1985) Severe leucopenia in fatal lithium poisoning. Br Med J 290: 517CrossRefGoogle Scholar
  78. Greger RF (1995) Excretion of Li*. In: Greger RF, Knauf H, Mutschler E (eds) Diuretics. Springer, Berlin Heidelberg New York Tokyo, pp 249–250Google Scholar
  79. Grell W (1981) Pharmakokinetik und Toxikologie des Lithiums. Bibliotheca Psychiatrica 161: 69–103Google Scholar
  80. Grell W, Van Calker D (1983) Lithium: Grundlagen und Therapie. In: Langer G, Heimann II (Hrsg) Psychopharmaka. Grundlagen und Therapie. Springer, Wien New York, S 161–202Google Scholar
  81. Grell W, Schölderle M (1986) Rezidivprophylaxe affektiver Psychosen mit Lithium. In: moi.leroeri.inghaiisen B, gpm. W (Hrsg) Die Lithiumtherapie. Nutzen, Risiken, Alternativen. Springer, Berlin Heidelberg New York Tokyo, S 138–163Google Scholar
  82. Grell W, Schmidt S (1988) Absetzsyndrome hei Antidepressiva, Neuroleptika und Lithium. Munch Med Wochenschr 130: 704–707Google Scholar
  83. Grell W, Patscheke H, Brossmer M (1972) Effects of lithium and other monovalentcations on the ADP-induced platelet aggregation in human plateletrich plasma. FERS Lett 26: 271CrossRefGoogle Scholar
  84. Grell W, Stoltzenburg Mc, Ímairhofer ML, Haag M (1985) Lithium dosage in the elderly. A study with matched age groups. J Affect Disord 9: 1–4CrossRefGoogle Scholar
  85. Grube M, Hartwicii P (1990) Maintenance of antidepressant effect of sleep deprivation with the help of lithium. Eur Arch Psychiatry Neurol Sci 240: 60–61CrossRefGoogle Scholar
  86. HalljE, Glyton AC, JacksonTE (1977) Control of glomerular filtration by the reninangiotensin system. Am J Physiol 233: F 366-F 372Google Scholar
  87. Hauler E, Binder RL (1990) Clozapine and seizures. Am J Psychiatry 147: 1069–1071Google Scholar
  88. Hansen HE, Amdisen A (1978) Lithium intoxication. Report of 23 cases and review of 100 cases from the literature. Quart J Med 47: 123–144Google Scholar
  89. Hansen HE, Amdisen A (1990) Lithium intoxication and acute renal failure. Lithium Therapy Monogr 0: 134–142Google Scholar
  90. Havdala HS, borison RI., diamond RI (1979) Potential hazards and application of lithium in anesthesiology. Anesth 50: 534–537CrossRefGoogle Scholar
  91. Hay G, Simpson N (1982) Neurotoxicity associated with therapeutic serum lithium levels. Lancet ii: 160–161Google Scholar
  92. Helmchen H (1990) Gestuftes Vorgehen bei Resistenz gegen Antidepressiva-Therapie. In: Müller HJ (Hrsg) ‘l’herapieresistenz unter Antidepressiva-Behandlung. Springer, Berlin Heidelberg New York Tokyo, S 237–250Google Scholar
  93. Helmchen H, Kanowski S (1971) EEG-Veränderungen unter Lithium-Therapie. Nervenarzt 42: 144–148PubMedGoogle Scholar
  94. Helmchen H, Hoffmann I, Kanowski S (1969) Paroxysmale Muskelschwäche bei Lithiumtherapie. Pharmakopsychiatrie 2: 269–273CrossRefGoogle Scholar
  95. Heninger GR, Charney DS, Sternberg DE (1983) Lithium carbonate augmentation of antidepressant treatment. Arch Gen Psychiatry 40: 1335–1342PubMedGoogle Scholar
  96. Hetmar O, Clemmesen I, Adffog Ed J, Rafaflseno J (1987) Lithium: long-term effects on the kidney. III. Prospective study. Acta Psychiatr Scand 75: 251–258PubMedCrossRefGoogle Scholar
  97. Hetmar O, Jailpovtsen L, Ladefoged J, Bolwio TG (1991) Lithium: long-term effects on the kidney. A prospective follow-up study ten years after kidney biopsy. Br J Psychiat 158: 53–58CrossRefGoogle Scholar
  98. Hill GE, Wong KC, Hodges MR (1977) Lithium carbonate and neuromuscular blocking agents. Anesth 46: 122–126CrossRefGoogle Scholar
  99. Himmeliiocii JM, Forrest J, Neil JF, Petre TP (1977) Thiazide-lithium synergy in refractory mood swings. Am J Psychiatry 134: 149–152Google Scholar
  100. Holzman PS, O’brian C, Waternaux C (1991) Effects of lithium treatment on eye movements. Biol Psychiatry 29: 1001–1015PubMedCrossRefGoogle Scholar
  101. Hsu LKG (1984) Treatment of bulimia with lithium. Am J Psychiatry 141: 1260–1262PubMedGoogle Scholar
  102. Huang LG (1974) Lithium intoxication with coadministration of a loop-diuretic. J Med 290: 748–749Google Scholar
  103. Hlllin RP, Mcdonald R, Allsopp MNE (1972) Prophylactic lithium in recurrent affective disorders. Lancet i: 1044–1046Google Scholar
  104. Hurtig H, Pyson W (1974) Lithium toxicity enhanced by diuresis. N Engl J Med 290: 748–749PubMedGoogle Scholar
  105. Iha AK, Stein GS, Fenwick P (1996) Negative interaction between lithium and electroconvulsive therapy: a case-control study. Br J Psychiatry 168: 241–243CrossRefGoogle Scholar
  106. Jacobson SJ, Jones K, Johnson K, Ceolin L, Kaur P, Sahn D, Donnenfeld A E, Rieder M, Santelli R, Smythe J, Pastlszak A, Einarson T, Koren G (1992) Prospective multicentre study of pregnancy outcome after lithium exposure during first trimester. Lancet 339: 530–533PubMedCrossRefGoogle Scholar
  107. Jaeger A, Sadder P, Kopferschmitt J, Trrtsch L, Flesch F (1993) When should dialysis be performed in lithium poisoning? A kinetic study in 14 cases of lithium poisoning. Clin Toxicol 31 (3): 429–447CrossRefGoogle Scholar
  108. Jefferson JW, Ayd FJ (1983) Combining lithium and antidepressants. J Clin Psychopharmacol 3: 303–307PubMedCrossRefGoogle Scholar
  109. Jorfe RT, Levi’it AJ, Bagby RM, Macdonald C, Singer W (1993a) Predictors of response to lithium and triiodothyronine augmentation of antidepressants in tricyclic nonresponders. Br J Psychiatry 163: 574–578CrossRefGoogle Scholar
  110. Jorfe RT, Singer W, Levirr AJ, Macdonald C (1993b) A placebocontrolled comparison of lithium and triiodothyronine augmentation of tricyclic antidepressants in unipolar refractory depression. Arch Gen Psychiatry 50: 387–393Google Scholar
  111. Johnson FN (1988) Lithium and the endocrine system. Karger, Basel (Lithium therapy monographs, vol 2Google Scholar
  112. Johnson Fn, Amdisen A (1986) Der historische Hintergrund der Lithiumtherapie undprophylaxe. In: MÜLLEROERLINGHAHSEN B, GRELL W (Hrsg) Die Lithiumtherapie. Nutzen, Risiken, Alternativen. Springer, Berlin Heidelberg New York Tokyo, S 1–4Google Scholar
  113. Julius SC, Brenner RP (1987) Myoclonic seizures with lithium. Rio] Psychiatry 22: 1184–1190Google Scholar
  114. Kampf D (1986) Lithium und Nierenfunktion. In: Mülleroerlinghalsen B, Grell W (Ilrsg) Die Lithiumtherapie. Nutzen, Risiken, Alternativen. Springer, Berlin Heidelberg New York Tokyo, S 286–296Google Scholar
  115. Kane JM, Quitkin FM, Rifkin A, Ramoslorenzi JR, Nayak DD, Howard A (1982) Lithium carbonate and imipramine in the prophylaxis of unipolar and bipolar II illness. A prospective, placebocontrolled comparison. Arch Gen Psychiatry 39: 1065–1069PubMedGoogle Scholar
  116. Kanowski S, Mülleroerlinghausen B (1972) Need for additional medication in outpatients during 3 years of prophylactic lithium treatment. In: Ban Ta, Boissier JR et al. (eds) Pro-ceedings VIIIth CINP Congress, Copenhagen. North Holland, Amsterdam, pp 105–108Google Scholar
  117. Kantor C, Mc Nevin S, Zeichner P, Harper I, Krenn M (1986) The benefit of lithium carbonate adjunct in refractory depression - fact or fiction? Can J Psychiatry 31: 416–418PubMedGoogle Scholar
  118. Kaschka WP (1986) Welche Antidepressiva sind in der Schwangerschaft geeignet? Fortschr Med 104: 20–21Google Scholar
  119. Kaschka WP (1987) Fragen im Zusammenhang mit Anästhesie und Operation bei psychiatrisehen Patienten. Nervenheilkunde 6: 249–254Google Scholar
  120. Kaschka WP (1988) Intoxikationen. Nervenheilkunde 7: 311–317Google Scholar
  121. Kaschka WP (1990) Therapie mit Lithiumsalzen. Fundamenta Psychiatrica 4: 148–156Google Scholar
  122. Kaschka WP (1993a) Klinik der Lithiumbehandlung. In: Riederer P, Laux G, Poldinger W (Hrsg) Neuro-Psychopharmaka, Bd 3. Springer, Wien New York, S 493–523Google Scholar
  123. Kasciika WP (1993b) Experimentelle und klinische Pharmakologie des Lithiums. In: Riederer P, Laux G, Poldinger W (Hrsg) Neuro-Psychopharmaka, Bd 3. Springer, Wien New York, S 472–482Google Scholar
  124. Kaschka WP (1997) Die Lithiumintoxikation. In: Mülleroi.Rlinghausl:N B, Grail W, Berghöei:R A (Hrsg) Die Lithiumtherapie. Nutzen, Risiken, Alternativen, 2. Aufl. Springer, Berlin Heidelberg New York Tokio, S 424–434Google Scholar
  125. Kaschka WP (1998) Therapie mit Lithiumsalzen. In: Barocka A (Hrsg) Psychopharmakotherapie in Klinik und Praxis. Schattauer, Stuttgart New York, S 192–200Google Scholar
  126. Kaschka WP, Konig F (1996) Die therapieresistente Depression. In: Kaschka Wp (Hrsg) Neurobiologische Forschung und psychiatrische Therapie. Karger, Basel, S 116–130Google Scholar
  127. Katona CLE (1988) Lithium augmentation in refractory depression. Psychiatr Dev 2: 153–171Google Scholar
  128. Katona CLE, Finch EJI. (1991) Lithium augmentation for refractory depression in old age. In: Amsterdam Jd (ed) Advances in neuropsychiatry and psychopharmacology, vol 2. Refractory depression. Raven Press, New York, pp 177–184Google Scholar
  129. Katona CLE, Abousaleh MT, Harrison DA, Nairac BA, Edwards DRL, Lock T, Burns RA, Robertson MM (1995) Placebo-controlled trial of lithium augmentation of fluoxetine and lofepramine. Br J Psychiatry 166: 80–86PubMedCrossRefGoogle Scholar
  130. Keller MB, Lavori PW, Kane JAI, Gelenberg AJ, Rosenbaum JF, Walzer EA, Baker LA (1992) Subsyndromal symptoms in bipolar disorder. A comparison of standard and low serum levels of lithium. Arch Gen Psychiatry 49: 371–376Google Scholar
  131. Kerry RJ, Owen G, Michaelson J (1983) Possible toxic interaction between lithium and piroxicam. Lancet i: 418–419Google Scholar
  132. Koczerginski D, Kennedy SH, Swinson RP (1989) Clonazepam and lithium - a toxic combination in the treatment of mania? Int Clin Psychopharmacol 4: 195–199CrossRefGoogle Scholar
  133. Konuziei AJR (1984) Extreme lithium intoxication without severe symptoms. Hosp Commun Psychiat 35: 727–728Google Scholar
  134. Kosten1’R, Forrest JN (1986)“leatmentofsevere lithium-induced polyuria with amiloride. Am J Psychiatry 143: 1563–1568PubMedGoogle Scholar
  135. Koufen H, Consbruch U (1972) Die Lithium-Intoxikation. Nervenarzt 43: 145–152PubMedGoogle Scholar
  136. Kramlinger KG, Post RM (1989) Adding lithium carbonate to carbamazepine: antimanic efficacy in treatment-resistant mania. Acta Psychiatr Scand 79: 378–385PubMedCrossRefGoogle Scholar
  137. Kramlinger KG, Post RM (1990) Addition of lithium carbonate to carbamazepine: hematological and thyroid effects. Am J Psychiatry 147: 615–620PubMedGoogle Scholar
  138. Lassen E, Vestergaard P, Thomsen K (1986) Renal function of patients in long-term treatment with lithium citrate alone or in combination with neuroleptics and antidepressant drugs. Arch Gen Psychiatry 43: 481–482PubMedGoogle Scholar
  139. Lenz G, Wolf R (1986) Prophylaxe der schizoaffektiven Psychdsen. In: Mülleroeriinghausen B, Grell W (Hrsg) Die Lithiumtherapie. Nutzen, Risiken, Alternativen. Springer, Berlin Heidelberg New York Tokyo, S 164–172Google Scholar
  140. Lerer B (1985) Studies on the role of brain cholinergie systems in the therapeutical mechanism and adverse effects of ECT and lithium. Biol Psychiatry 20: 20–40PubMedCrossRefGoogle Scholar
  141. Levinson ML, Lipsy RJ, Fuller DK (1991) Adverse effects and drug interactions associated with fluoxetine therapy. DICP Ann Pharmacother 25: 657–661Google Scholar
  142. Linder J, Fyro B, Pettersson U, Werner S (1989) Acute antidepressant effect of lithium is associated with fluctuation of calcium and magnesium in plasma. A doubleblind study on the antidepressant effect of lithium and clomipramine. Acta Psychiatr Scand 80: 27–36PubMedCrossRefGoogle Scholar
  143. Lingjaerde O, Edlund AH, Gormsen CA, Gottfries CG, Iiaugstad A, Iiermann IL, Iiollnagei. P, Makimaitila A, Rasmussen KE, Remvig J, Robak OH (1974) The effect of lithium carbonate in combination with tricyclic antidepressants in endogenous depression. A double-blind, multicenter trial. Acta Psychiatr Scand 50: 233242Google Scholar
  144. Linnoiia M, Saario I, Maki M (1974) Effect of treatment with diazepam or lithium and alcohol on psychomotoric skills related to driving. Eur J Clin Pharmacol 7: 337-342CrossRefGoogle Scholar
  145. Lippmann SB, Elmallakh R (1994) Can electroconvulsive therapy be given during lithium treatment. Lithium 5: 205–209Google Scholar
  146. Lown B, Verrier RL, Rabinowitz SH (1977) Neural and psychologie mechanisms and the problem of sudden cardiac death. Am J Cardiol 39: 890–902PubMedCrossRefGoogle Scholar
  147. Lungershausen E, Kaschk.AWP (1988) Risikoerfassung und optimierende Therapie bei Psychosen, Depressionen, Suchterkrankungen. In: Rugheimrr E, Pascih TH (Hrsg) Vorbereitung des Patienten zu Anästhesie und Operation. Springer, Berlin Heidelberg New York Tokyo, S 141–165.Google Scholar
  148. Maj M (1988) Lithium prophylaxis of schizoaffective disorders: a prospective study. J Affect Disord 14: 129–135PubMedCrossRefGoogle Scholar
  149. Mander AJ (1986) Is there a lithium withdrawal syndrome? Br J Psychiatry 149: 498–501PubMedCrossRefGoogle Scholar
  150. Manto M, Gooaux E, Seillier M, Mantia M,Lacquy J (1994) Syndrome c¨¦r¨¦belleux secondaire ¨¤ une intoxication en lithium: ¨¦tude cin¨¦matique et ¨¦lectro-myographique de deux cas. Rev Neurol (Paris) 150: 467–470Google Scholar
  151. Martin TG, Mallinger AG, Mici Ielson EA, Schnei- DER SM (1991) RBC lithium kinetics during an acute intoxication treated with hemodialysis. Veterinary Hum Toxicol 33: 363Google Scholar
  152. Mc Evoy GK (ed) (1984) Drug information. American Society of Hospital Pharmacists, Bethesda, pp 824–832Google Scholar
  153. Melia PI (1970) Prophylactic lithium: a double-blind trial in recurrent affective disorders. Br J Psychiatry 116: 621–624PubMedCrossRefGoogle Scholar
  154. Mes’ier R, Toren P, Mizrachi I, Wolmer L, Karni N, Weizman A (1995) Caffeine withdrawal increases lithium blood levels. Biol Psychiatry 37: 348–350CrossRefGoogle Scholar
  155. Moss GR, James CR (1983) Carbamazepine and lithium carbonate synergism in mania. Arch Gen Psychiatry 40: 588–589PubMedGoogle Scholar
  156. Moilbauer HD (1986) Die Lithiumintoxikation. In: Mullerouoinghafsen B, Greet W (Hrsg) Die Lithiumtherapie. Nutzen, Risiken, Alternativen. Springer, Berlin Heidelberg New York Tokyo, S 329–336Google Scholar
  157. Mulleroerlingi Iausen B (1986) Wechselwirkungen von Lithiumsalzen mit anderen Arzneimitteln. In: Müllerol Rlinghausen B, Grell W (Hrsg) Die Lithiumtherapie. Nutzen, Risiken, Alternativen. Springer, Berlin Heidelberg New York Tokyo, S 347–355Google Scholar
  158. Mulleroerlinghausen B (1986a) Wirkung Von Lithium auf Sexualfunktion und Schwangerschaft. In: Motteroerlinghausen B, Grell W (Hrsg) Die Lithiumtherapie.: Nutzen, Risiken, Alternativen. Springer, Berlin Ieidelberg New York Tokyo, S 323–328Google Scholar
  159. Mi`Lleroerltnghaten B (1986b) Wechselwirkungen von Lithiumsalzen mit anderen Arzneimitteln. In: MÜLLEROERLINGHAUSEN B, GREII. W (Ilrsg) Die Lithiumtherapie. Nutzen, Risiken, Alternativen. Springer, Berlin Heidelberg New York Tokyo, S 347–355Google Scholar
  160. Mz.Ieroerlnghaisen B (1997) Unerwünschte Wechselwirkungen von Lithiumsalzen mit anderen Arzneimitteln. In: Müllerofrlinghausen B, Grell W, Berghöfer A (Hrsg) Die Lithiumtherapie, 2. Aufl. Springer, Berlin Heidelberg New York Tokyo, S 424–434Google Scholar
  161. Mulleroerlinghausen B, Greii W (1986a) Praktische Ratschläge zur Durchführung und Kontrolle einer Lithiumbehandlung. In: mülleroerlinghausen b, greii. W (Hrsg) Die Lithiumtherapie. Nutzen, Risiken, Alternativen. Springer, Berlin Heidelberg New York Tokyo, S 369–389Google Scholar
  162. Mulleroerlinghausen B, Grell W (Hrsg) (1986b) Die Lithiumtherapie. Nutzen, Risiken, Alternativen. Springer, Berlin Heidelberg New York TokyoGoogle Scholar
  163. Mllieroerlinghausen B, Ahrens B, Volk J, Groe P, Grof E, Schou M, Vestergaard P, Lenz G, Simhandl C, Trau K, Wolf R (1991) Reduced mortality of manicdepressive patients in longterm lithium treatment: an international collaborative study by IGSLI. Psychiatry Res 36: 329–331CrossRefGoogle Scholar
  164. Muff S, Meienberg O (1983). Irreversible neurologische Schäden durch Lithiumtherapie. Dtsch Med Wochenschr 108: 663–665PubMedCrossRefGoogle Scholar
  165. Mlmenthaler M (1986) Neurologie, 8. Aufl. Thieme, Stuttgart New YorkGoogle Scholar
  166. Nadaraiah J, Stein GS (1985) Piroxicam induced lithium toxicity. Ann Rheumatic Dis 44: 502CrossRefGoogle Scholar
  167. Nagaraia D, Taly AB, Sahu RN, Ctiannabasavanna SM, Narayanan HS (1987) Permanent neurological sequelae due to lithium toxicity. Clin Neurol Neurosurg 89: 31–34CrossRefGoogle Scholar
  168. Naramoto A, Koizumi N, Trot’ N, Shigemalsit II (1993) An autopsy case of cerebellar degeneration following lithium intoxication with neuroleptic malignant syndrome. Acta Pathol Japon 43: 55–58Google Scholar
  169. Navis GJ, De Dong PE, De Zeeuw D (1989) Volume homeostasis, angiotensin converting enzyme inhibition, and lithium therapy. Am J Med 86: 621PubMedCrossRefGoogle Scholar
  170. Naylor GJ, Mc Haro A (1975) Profound hypothermia on combined lithium carbonate and diazepam treatment. Br Med J 2: 22CrossRefGoogle Scholar
  171. Nilsson A (1995) Mortality in recurrent mood disorders during periods on and off lithium. Pharmacopsychiat 28: 8–13CrossRefGoogle Scholar
  172. Nilsson A, Axelsson R (1990) Lithium discontinuers. I. Clinical characteristics and outcome. Acta Psychiatr Scand 82: 433-438PubMedCrossRefGoogle Scholar
  173. Nilsson A, Axelsson R (1991) Lithium discontinuers. II. Therapeutic outcome. Acta Psychiatr Scand 84: 78–82NPubMedCrossRefGoogle Scholar
  174. Nishiwaki T, Tanaka K, Sekiya S (1996) Acute lithium intoxication in pregnancy. Int J Gynecol Obst 52: 191–192CrossRefGoogle Scholar
  175. Normann C, Brandt C, Berger M, Walden J (1998) Delirium and persistent dyskinesia induced by a lithiumneuroleptic interaction. Pharmacopsychiatry 31: 201–204PubMedCrossRefGoogle Scholar
  176. Okcsa MD, Crystal LJT (1994) Clinical manifestations and management of acute lithium intoxication. Am J Med 97: 383–389CrossRefGoogle Scholar
  177. Ong ACM, Handler CE (1991) Sinus arrest and asystole due to severe lithium intoxication. Int J Cardiol 30: 364–366PubMedCrossRefGoogle Scholar
  178. Peiffer J (1981) Clinical and neuropathological aspects of longterm damage to the central nervous system after lithium medication. Arch Psychiat Neurol Sci 231: 41–60CrossRefGoogle Scholar
  179. Perrier A, Martin P-Y, Favre H, Muller Af, Urban P, Chevrolet J-C (1991) Very severe selfpoisoning lithium carbonate intoxication causing a myocardial infarction. Chest 100: 863–865PubMedCrossRefGoogle Scholar
  180. Perry PJ, Calloway RA, Cook BL, Smith RE (1984) Theophylline precipitated alterations of lithium clearance. Acta Psychiatr Scand 69: 528–537Google Scholar
  181. Persson G (1972) Lithium prophylaxis in affective disorders. An open trial with matched controls. Acta Psychiatr Scand 48: 462–479CrossRefGoogle Scholar
  182. Petersen V, Hvidt S, Thomsen K, Schou M (1974) Effect of prolonged thiazide treatment on renal lithium clearance. Br Med J 3: 143–145Google Scholar
  183. Plenge P, Mellerup ET, Bolwig TG, Brun C, Hetmar O, Ladefoged J, Larsen S, Rafaelsen OJ (1982) Lithium treatment: does the kidney prefer one daily dose instead of two? Acta Psychiatr Scand 66: 121–128CrossRefGoogle Scholar
  184. Prien RF, Caffey Em JR, Klet T (1973a) Prophylactic efficacy of lithium carbonate in manic depressive illness. Arch Gen Psychiatry 28: 337–341Google Scholar
  185. Prien RE, Klett J, Caffey Em JR (1973b) Lithium carbonate and imipramine in prevention of affective episodes. A comparison in recurrent affective illness. Arch Gen Psychiatry 29: 420–425Google Scholar
  186. Prien RF, Kt PFER DJ, Mansky PA, Small JG, Tuason VB, Voss C B, Johnson WE (1984) Drug therapy in the prevention of recurrences in unipolar and bipolar affective disorders. Arch Gen Psychiatry 41: 1096–1104PubMedGoogle Scholar
  187. Quitkin Fm, Kane J, Rifkin A, Ramoslorenzi JR, Nayak DV (1981) Prophylactic lithium carbonate with and without imipramine for bipolar 1 patients. A doubleblind study. Arch Gen Psychiatry 38: 902–907PubMedGoogle Scholar
  188. Ragheb M (1987a) Ibuprofen can increase serum lithium level in lithium-treated patients. J Clin Psychiatry 48.161–163Google Scholar
  189. Ragheb Ma (1987b) Aspirin does not significantly affect patients’ serum lithium levels. J Clin Psychiatry 48: 425Google Scholar
  190. Ragheb M, Powell AL (1986) Lithium interaction with sulindac and naproxen. J Clin Psychopharmacol 6: 150–154PubMedCrossRefGoogle Scholar
  191. Ragheb MA, Powell AL (1986) Failure of sulindac to increase serum lithium levels. J Clin Psychiatry 47: 33–34Google Scholar
  192. Randall S, Hartley CE, Buchan A, Lancaster S, Skinner GRB (1991) Effect of lithium on viral replication. In: Birch Nj (ed) Lithium and the cell: pharmacology and biochemistry. Academic Press, London, pp 99–112Google Scholar
  193. Raskin A, Schulterbrandt J, Reatig N, Mckfon JJ (1969) Replication of factors of psychopathology in interview, ward behavior, and self-report ratings of hospitalized depressives. J Nerv Ment Dis 148: 87–98PubMedCrossRefGoogle Scholar
  194. Rem¨¦ Ch E, Urner U, I Iuber CH, Bush RA, Kopp II (1991) Lithium effects in the retina: experimental and clinical observations. In: Christen Y, Doly M, Droylefaix MT (eds) Retinopathies et Neurotransmission. Les S¨¦minaires Ophtalmologiques d’IPSEN, Tome 3. Springer, Berlin Heidelberg New York Tokyo, pp 37–49Google Scholar
  195. Riedl U, Barocka A, Kolem H, Demling J, Kaschka WP, Schelp R, Stemmler M, Eberr D (1997) Duration of lithium treatment and brain lithium concentration in patients with unipolar and schizoaffective disorder a study with magnetic resonance spectroscopy. Biol Psychiatry 41: 844–850PubMedCrossRefGoogle Scholar
  196. Rosebush P, Stewart T (1989) A prospective analysis of 24 episodes of neuroleptic malignant syndrome. Am J Psychiatry 146: 717–725PubMedGoogle Scholar
  197. Rybakowski Jk, Amsterdam Jd (1991) Lithium prophylaxis and recurrent labial herpes infections. Lithium 2: 43–47Google Scholar
  198. Ryrakowski J, Lehman W, Kanarkowski R, Matkowski K (1991) Possible pharmacokinetis interaction of lithium and carbamazepine. Lithium 2: 183–184Google Scholar
  199. Saarnivaaral, Emma Ertama P (1992) Interactions of lithium/ruhidium and six muscle relaxants. A study on the rat phrenic nervehemidiaphragrn preparation. Anaesthesist 41: 760–764Google Scholar
  200. Salter D, Coppen A (1983) Furosemide: a safe diuretic during lithium therapy? J Affect Disord 5: 289–292CrossRefGoogle Scholar
  201. Sansone ME, Ziegler DK (1985) Lithium toxicity: a review of neurologic complications. Clin Neuropharmacol 8: 242–248PubMedCrossRefGoogle Scholar
  202. Schneider JA, Mirra SS (1994) Neuropathologie correlates of persistent neurologic deficit in lithium intoxication. Ann Neurol 36: 928–931PubMedCrossRefGoogle Scholar
  203. Sciiolderle M, Grell W (1986a) Behandlung derakuten Depression mit Lithium. In: Mülleroerlinghausen B, Greii W (Hrsg) Die Lithiumtherapie: Nutzen, Risiken, Alternativen. Springer, Berlin Heidelberg New York Tokyo, S 130–137Google Scholar
  204. Schölderle M (1986b) Lithium in der Neurologie. In: Mulleroerlinghausen B, Grell W (Hrsg) Die Lithiumtheyapie Nutzen, Risiken, Alternativen. Springer, Berlin Heidelberg New York Tokyo, S 231–237Google Scholar
  205. Schöpf J (1993) Exkurs: Lithium Augmentations Therapie. In: Riederer P, Laux G, Poldinger W (Hrsg) Neur Psychopharmaka, Bd 3. Springer, Wien New York, S 524–527Google Scholar
  206. Sciöpe J (1998) Exkurs: Lithium-AugmentationsTherapie. En: Riederer P, Laux G, Pöldinger W (Hrsg) Neuro-Psychopharmaka, Bd 3. Springer, Wien New York, S 524–527Google Scholar
  207. Schöpf J, Baumann P, Lemarchand T, Rey M (1989) Treatment of endogenous depressions resistant to tricyclic antidepressants of related drugs by lithium addition, Results of a placehocontrolled double-blind study. Pharmacopsychiatry 22: 183–187PubMedCrossRefGoogle Scholar
  208. Schou M (1974) Heutiger Stand der LithiumRezidivprophylaxe bei endogenen affektiven Erkrankungen. Nervenarzt 45: 397–418PubMedGoogle Scholar
  209. Schou M (1979) Lithium in the treatment of other psychiatric and nonpsychiatric disorders. Arch Gen Psychiatry 36: 856–859PubMedGoogle Scholar
  210. Scxou M (1984) Longlasting neurological sequelae after lithium intoxication. Acta Psychiatr Scand 70: 594–602Google Scholar
  211. Sghoo M (1987) Clinically significant lithium interactions. Review and recommendations. Eur J Psychiatry 1: 42–47Google Scholar
  212. Scxou M, Hippius H (1983) LithiumProphylaxe und operative Eingriffe. Munch Med Wochenschr 125: 705–706Google Scholar
  213. Schou M, Joelnielsen N, Stromgren E, Voldry H (1954) The treatment of manic psychoses by the administration of lithium salts. J Neurol Neurosurg Psychiatry 17: 250–260PubMedCrossRefGoogle Scholar
  214. Sul M, Amdisen A, L’rap Jensen J (1968) Lithium poisoning. Am J Psychiatry 125: 520–527Google Scholar
  215. Sciioc M, Amdisen A, Thomsen K, Vestergaard P, Hetmar O, Mellerup Et, Plenge P, Rafaelsen Oj (1982) Lithium treatment regimen and renal water handling: the significance of dosage pattern and tablet type examined through comparison of results from two clinics with different treatment regimens. Psychopharmaeulogy 77: 387–390CrossRefGoogle Scholar
  216. Sellers J, Tyrer P, Wiiitei.Ey A, Banks DC, Barer DII (1982) Neurotoxic effects of lithium with delayed rise in serum lithium levels. Br J Psychiatry 140: 623–625PubMedCrossRefGoogle Scholar
  217. Shalmi M, Rasmgsen II, Amtorp O, Christensen S (1990) Effect of chronic oral furosemide administration on the 24-hour cycle of lithium clearance and electrolyte excretion in humans. Eur J Clin Pharmacol 3: 275–280CrossRefGoogle Scholar
  218. Siiannon MW, Eisen T, Linakts J, Woolf A (1990) Clinical features of acute versus chronic lithium intoxication. Ann Emerg Med 19: 630CrossRefGoogle Scholar
  219. Shopsin B, Johnson G, Gershon S (1970) NeLIrotoxicity with lithium: differential drug responsiveness. Int Pharmacopsychiatry J 5: 170–182Google Scholar
  220. Siiukla S, Mukheriee S (1984) Lichen simplex chronicus during lithium treatment. Am J Psychiatry 141: 909–910Google Scholar
  221. Shtkla S, Godwin CD, Long LEB, Miller MG (1984) Lithiumcarbamazepine neurotoxicity and risk factors, Am J Psychiatry 141: 1604–1606Google Scholar
  222. Singer I (1970) Lithium in mania. Clin Pharmacol Ther 11: 168–187Google Scholar
  223. Sobanski T, Bagli M, Laüx G, Rao ML (1997) Serotonin syndrome after lithium add-on medication to paroxetine. Pharmacopsychiatry 30: 106–107PubMedCrossRefGoogle Scholar
  224. Solomon JG (1979) Seizures during lithiumami triptylina. Postgrad Med 66: 145–148PubMedGoogle Scholar
  225. Souza FGM, Goodwin GM (1991) Lithium treatment and prophylaxis in unipolar depression: a metaanalysis. Br J Psychiatry 158: 666–675PubMedCrossRefGoogle Scholar
  226. Souz& FGM, Mander AJ, Fooco M, Dick H, Shearing CH, Goodwin GM (1991) The effects of lithium discontinuation and the noneffect of oral inositol upon thyroid hormones and cortisol in patients with bipolar affective disorder. J Affect Disord 22: 165–170CrossRefGoogle Scholar
  227. Spiess J, Hirsh SR (1978) Severe lithium toxicity with „normal“ serum concentrations. Br Med J 281: 815–816Google Scholar
  228. Spitzer R, Endicot’r J, Robins E (1978) Research diagnostic criteria: rationale and reliability. Arch Gen Psychiatry 35: 773–782PubMedGoogle Scholar
  229. Stallone F, Shelley E, Mendlewicz J, Fieve RR (1973) The use of lithium in affective disorders. III. A double-blind study of prophylaxis in hipolar illness. Am J Psychiatry 130: 1006–1010PubMedGoogle Scholar
  230. Stein G, Bernart M (1993) Lithium augmentation therapy in tricyclicresistant depression. A controlled trial using lithium in low and normal doses. Br J Psychiatry 162: 634–640PubMedCrossRefGoogle Scholar
  231. Stewart DE, Klompfnhouwer JL, Kendell Re, Van Iidlst AM (1991) Prophylactic lithium in puerperal psychosis. The experience of three centres. Br J Psychiatry 158: 393–397PubMedCrossRefGoogle Scholar
  232. Stoltzenburg MC, Greil W (1986) Behandlung der Manie mit Lithiumsalzen. In: mulleroerlinghausen B. Greil W (HISg) Die Lithiumtherapie. Nutzen, Risiken, Alternativen. Springer, Berlin Heidelberg New York Tokyo, S 116–129Google Scholar
  233. Taylor MA (1986) The validity of schizoaffective disorders: treatment and prevention studies. In: Marneros A, Tsuang MT (eds) Schizoaffective psychoses. Springer, Berlin Heidelberg New York ‘Tokyo, pp 94–114Google Scholar
  234. Thiesflechtner K, Mulleroerlinghausen B, Seibert W, Walther A, Greil W (1996) Effect of prophylactic treatment on suicide risk in patients with major affective disorders. Pharmacopsychiat 29: 103–107CrossRefGoogle Scholar

Copyright information

© Springer-Verlag/Wien 2002

Authors and Affiliations

  • B. Müller-Oerlinghausen
  • W P. Kaschka

There are no affiliations available

Personalised recommendations